The storylines故事线
Click a development’s source links to open the original article.点击进展下方的来源链接可打开原文。
Share buyback & capital return股份回购与股东回报
21 · 2024-01-02 → 2026-04-23
▾
Aier completed multiple share buybacks totaling ~590M yuan for equity incentives, and paid dividends.爱尔完成多次合计约5.9亿元的股份回购用于股权激励，并进行了现金分红。
2024-01-02Aier Eye Hospital completed the repurchase of 11.3104 million shares (0.12% of total share capital) via centralized bidding for a total amount of 204 million yuan, for equity incentive or employee stock ownership plans.爱尔眼科通过集中竞价方式完成回购1131.04万股（占总股本0.12%），成交总金额2.04亿元，用于股权激励或员工持股计划。
2024-02-02Aier Eye Hospital repurchased 11.3104 million shares (0.12% of total equity) via centralized竞价 trading for 204 million yuan, as part of a share buyback plan for equity incentives.爱尔眼科以集中竞价交易方式回购1131.04万股（占总股本0.12%），成交金额2.04亿元，用于股权激励计划。
2024-03-04Aier Eye Hospital repurchased 11.3104 million shares (0.12% of total equity) via centralized竞价 trading for 204 million yuan, for future equity incentive or employee stock ownership plan.爱尔眼科以集中竞价交易方式回购1131.04万股（占总股本0.12%），成交金额2.04亿元，用于股权激励或员工持股计划。
2024-04-02Aier Eye Hospital repurchased 11,310,377 shares (0.12% of total equity) via centralized bidding, with total expenditure of 203,616,286.52 yuan, as part of its second share buyback plan for equity incentives.爱尔眼科通过集中竞价方式回购11,310,377股（占总股本0.12%），成交总金额203,616,286.52元，作为第二次股份回购计划用于股权激励。
2024-05-06Aier Eye Hospital repurchased 11.31 million shares (0.12% of total) for 204 million yuan via centralized bidding.爱尔眼科以集中竞价方式回购1131.04万股（占总股本0.12%），成交金额2.04亿元。
2024-05-30Aier Eye Hospital announced 2023 annual dividend: 1.500225 yuan per 10 shares (total ~1.395 billion yuan), ex-dividend date June 6, 2024.爱尔眼科公告2023年度分红：每10股派1.500225元（合计约13.95亿元），除权除息日2024年6月6日。
2024-06-06Aier Eye Hospital completed its 2023 annual equity distribution: record date June 5, ex-dividend date June 6, 2024.爱尔眼科完成2023年度权益分派：股权登记日2024年6月5日，除权除息日2024年6月6日。
2024-07-01Aier Eye Hospital repurchased 12.6587 million shares via centralized竞价 trading as of June 30, 2024, totaling 218 million yuan, representing 0.14% of total share capital.爱尔眼科截至2024年6月30日以集中竞价交易方式回购公司股份1265.87万股，成交总金额2.18亿元，占总股本0.14%。
2024-07-02Aier Eye Hospital adjusted the upper limit of its share buyback price from 26.98 yuan/share to 26.83 yuan/share due to the implementation of the 2023 annual dividend distribution.爱尔眼科因2023年年度分红派息实施完毕，将回购股份价格上限由26.98元/股调整为26.83元/股。
2024-09-03Aier Eye Hospital repurchased 12.7987 million shares (0.14% of total equity) via centralized bidding as of Aug 31, 2024, for total 220 million yuan.截至2024年8月31日，爱尔眼科以集中竞价方式回购公司股份1279.87万股（占总股本0.14%），成交总金额2.2亿元。
2024-10-25Aier Eye Hospital completed its share buyback plan, repurchasing 12.7987 million shares (0.14% of total equity) for a total of 220 million yuan, with prices ranging from 10.65 to 18.56 yuan per share.爱尔眼科完成股份回购计划，以集中竞价方式回购1279.87万股（占总股本0.14%），成交总金额2.2亿元，回购价格区间10.65-18.56元/股。
2025-02-13Aier Eye Hospital announced it has completed two share buybacks totaling approximately 590 million yuan, and will disclose any further buyback plans per regulations.爱尔眼科宣布已完成两期股票回购，金额合计约5.9亿元，后续如有进一步回购计划将按规则披露。
2025-05-23Repurchased and cancelled 1.6178 million restricted shares (0.0173% of total share capital) at 11.96 yuan/share from 207 former employees who left the company, reducing total shares from 9.327 billion to 9.325 billion.对207名离职激励对象所持161.78万股限制性股票以11.96元/股进行回购注销，占总股本0.0173%，总股本由93.27亿股变更为93.25亿股。
2025-06-27Aier Eye Hospital stated on its investor interaction platform that it has completed two rounds of stock buybacks.爱尔眼科在互动平台回答投资者提问时表示，公司已完成两期股票回购。
2025-08-18Selected into the 2025 Dividend Payout Top 100 list by the China Association for Public Companies; cumulative cash dividends reached 7.12 billion yuan since listing.入选中国上市公司协会2025年股利支付率100强榜单；上市以来累计现金分红达71.2亿元。
2025-11-10Aier Eye Hospital announced a 2025 interim dividend plan: a cash dividend of 0.8 yuan (pre-tax) per 10 shares, totaling 743.5 million yuan, based on 9.294 billion shares (excluding treasury shares). No share transfer or capital reserve increase.爱尔眼科公告2025年中期分红预案：以扣除回购专户后92.94亿股为基数，每10股派发现金红利0.8元（含税），合计派现7.44亿元，不送红股、不转增股本。
2025-12-11Aier Eye Hospital disclosed that the 2025 interim dividend plan has been approved by the extraordinary general meeting and will be distributed within two months.爱尔眼科披露，2025年中期分红预案已获临时股东大会审议通过，将在两个月内完成分配。
2026-01-07Aier Eye Hospital announced a 2025 interim cash dividend of 0.8 yuan per 10 shares (pre-tax), totaling approximately 744 million yuan, with the record date on January 14, 2026, and ex-dividend date on January 15, 2026.爱尔眼科发布2025年中期分红派息实施公告，每10股派发现金红利0.8元（含税），合计约7.44亿元，股权登记日为2026年1月14日，除权除息日为1月15日。
2026-04-01Aier Eye Hospital announced that its 2025 annual report will be disclosed on April 24, 2026, and it will steadily increase dividend payout.爱尔眼科宣布2025年年报将于2026年4月24日披露，并将稳步提升分红力度。
2026-04-23Aier Eye Hospital reported FY2025 revenue of 22.353 billion yuan, up 6.53% YoY; net profit of 3.24 billion yuan, down 8.88% YoY; proposed dividend of 1 yuan per 10 shares.爱尔眼科2025年营收223.53亿元，同比增长6.53%；净利润32.4亿元，同比下降8.88%；拟每10股派1元。
2026-04-23Aier Eye Hospital's board approved a proposal to authorize the board to formulate a 2026 interim dividend plan.爱尔眼科董事会通过授权董事会制定2026年中期分红方案的议案。
Medical disputes & patient safety incidents医疗纠纷与患者安全事件
3 · 2024-01-02 → 2024-01-03
▾
Multiple patient safety incidents including alleged fake surgery, doctor punching patient, and anesthetic overdose death.多起患者安全事件，包括涉嫌假手术、医生殴打患者、麻醉过量致死等。
2024-01-02Patient at Yulin Aier Eye Hospital alleged 'fake surgery' due to residual silicone oil in the right eye after a vitrectomy; hospital claimed it was a common complication.玉林爱尔眼科患者因右眼硅油残留质疑“假手术”；院方称系常见并发症。
2024-01-03Guigang Aier Eye Hospital doctor Feng was found to have punched an 82-year-old patient during surgery; hospital issued an apology and the doctor was severely disciplined.贵港爱尔眼科医院医生冯某在手术中击打82岁患者头部；医院致歉并严肃处理涉事医生。
2024-01-03Baishan Aier Eye Hospital was ordered to suspend operations for 7 days and fined by the Baishan Health Commission for a Grade 1 Class A medical accident involving a patient death due to suspected anesthetic overdose.白山爱尔眼科医院因一级甲等医疗事故（患者疑因麻药过量死亡）被白山市卫健委责令停业整顿7天并处罚。
Military support & veteran charity programs拥军优属与老兵公益项目
4 · 2024-01-03 → 2026-01-30
▾
Aier launched military support hospitals and veteran cataract surgery programs, receiving government recognition.爱尔启动拥军医院和老兵白内障手术项目，获得政府表彰。
2024-01-03Ningde Aier Eye Hospital launched a 'Military Support Hospital' (拥军医院) in partnership with the local Veterans Affairs Bureau, offering free cataract surgeries to 22 veterans and subsidies for myopic surgery to 12 conscripts.宁德爱尔眼科医院与蕉城区退役军人事务局合作启动“拥军医院”，为22名退役老兵提供免费白内障手术，为12名征兵青年提供近视手术补贴。
2024-04-26Aier Eye Hospital released its 15th social responsibility report, highlighting 2023 achievements: cataract postoperative endophthalmitis rate 0.0166% (below national tertiary hospital average), and a 5-year, 100 million yuan program to support cataract surgeries for 60,000 low-income veterans.爱尔眼科发布第15份社会责任报告，2023年白内障术后眼内炎发生率0.0166%（低于国家三甲医院平均水平），并启动5年1亿元公益计划为6万例低保特困老年退役军人提供白内障手术支持。
2025-08-29Launched the 'Warm Veterans, Guarding Brightness' public welfare campaign in Huangshan, funded by Aier Eye Care Group with 1.62 million yuan for cataract, full-eye, and refractive surgeries for veterans and families.在黄山启动“情暖老兵·守护光明”公益行动，爱尔眼科集团出资162万元为退役军人及家属提供白内障、全眼病和屈光手术资助。
2026-01-30The Ministry of Veterans Affairs sent a letter of thanks to Aier Eye Hospital for its 'Warm Veterans, Protect Brightness' public welfare project, which has performed 67,504 cataract surgeries for veterans as of January 2026.退役军人事务部向爱尔眼科发来感谢信，其支持的“情暖老兵·守护光明”公益项目截至2026年1月已累计为退役军人成功实施白内障手术67504例。
Changsha Medical Center & '1+8+N' flagship hospitals长沙医学中心与'1+8+N'旗舰医院
6 · 2024-01-04 → 2026-03-18
▾
Establishment of Changsha Medical Center and multiple large regional flagship hospitals under the '1+8+N' strategy.设立长沙医学中心及多个大型区域旗舰医院，推进'1+8+N'战略。
2024-01-04Aier Eye Hospital Changsha Medical Center was officially established, aiming to deepen the 'Shared Global Ophthalmic Wisdom' strategy, focusing on international experts, cutting-edge technology, and digital ophthalmology.“爱尔眼科长沙医学中心”正式成立，旨在深化“共享全球眼科智慧”战略，聚焦国际专家引进、前沿技术和数字眼科。
2024-04-24Aier Eye Hospital launched a Difficult Eye Disease Consultation Platform at its Changsha Medical Center, featuring national expert studios, MDT, and telemedicine centers connecting 13 remote sub-centers.爱尔眼科在长沙医学中心启动疑难眼病会诊平台，包括全国名医工作室、多学科协作诊疗及远程医疗中心，连接13个远程分中心。
2024-07-15Aier Eye Hospital Changsha Medical Center established a difficult eye disease consultation platform, gathering domestic and international top ophthalmology experts to provide high-quality diagnosis and treatment services.爱尔眼科长沙医学中心正式打造疑难眼病会诊平台，汇聚国内外顶尖眼科专家，提供高质量诊疗服务。
2025-04-24Aier Eye Hospital disclosed that in 2024 it acquired 87 medical institutions, established the Changsha Medical Center, and advanced the '1+8+N' strategic layout.爱尔眼科披露2024年收购87家医疗机构，成立长沙医学中心，推进“1+8+N”战略布局。
2025-10-28Aier Eye Hospital Group disclosed that multiple large eye centers, including Hubei Aier, Liaoning Aier, Nanning Aier, and Shenzhen Binhai Aier, have been put into operation, marking key progress in its '1+8+N' strategy.爱尔眼科医院集团披露，包括湖北爱尔、辽宁爱尔、南宁爱尔、深圳滨海爱尔在内的多家大型眼科中心已陆续投入运营，表明“1+8+N”战略取得关键进展。
2026-03-18Aier Eye Hospital stated in an investor relations activity that its '1+8+N' strategy has seen 9 flagship hospitals basically completed and operational, entering a new phase of quality improvement.爱尔眼科在投资者关系活动中表示，“1+8+N”战略中9家旗舰医院已基本建成运营，进入提质新阶段。
QuanGuangSu (All-Optical) refractive surgery rollout全光塑屈光手术推广
11 · 2024-01-04 → 2026-06-18
▾
Aier launched and expanded the AI-based QuanGuangSu personalized refractive surgery across multiple hospitals in partnership with Alcon.爱尔与爱尔康合作，在多家医院推出并推广基于AI的全光塑个性化屈光手术。
2024-01-04Aier Eye Hospital performed the first 'QuanGuangSu' (全光塑) personalized refractive surgery in Guangzhou, using AI-based ray-tracing technology from Alcon to create a full-eye 3D model for customized correction.爱尔眼科在广州完成首例“全光塑”个性化屈光手术，采用爱尔康AI光迹追踪技术生成全眼3D模型进行定制矫正。
2024-01-31Aier Eye Hospital and Alcon (China) signed a strategic cooperation agreement for the 'QuanGuangSu' (全光塑) new refractive surgery procedure, combining Alcon's technology with Aier's clinical data.爱尔眼科与爱尔康（中国）签订全光塑新术式合作战略协议，结合爱尔康技术与爱尔临床数据。
2024-06-25Fuzhou Aier Eye Hospital introduced the 'QuanGuangSu' (All-Optical) myopia correction technology, based on real-eye 3D model and AI algorithm.福州爱尔眼科医院引入‘全光塑’近视矫正技术，基于真实眼3D模型和AI算法。
2024-07-22Quanzhou Aier Eye Hospital introduced 'All-Optical Sculpture' (QuanGuangSu) personalized myopia correction technology, utilizing AI algorithms and 3D eye models for customized surgery.泉州爱尔眼科医院引入“全光塑”个性化近视矫正技术，应用AI算法和眼3D模型，开启“全眼定制”屈光手术新时代。
2024-07-30Hengshui Aier Eye Hospital introduced 'All-Optical Sculpture' (QuanGuangSu) myopia correction technology, collecting over 138,000 data points per patient to build a 3D eye model using AI.衡水爱尔眼科医院引进“全光塑”近视矫正技术，术前收集患者眼部超13.8万个数据点，利用AI构建3D眼模型。
2024-08-07Quanzhou Aier Eye Hospital launched the 'QuanGuangSu' personalized refractive surgery technology, using light-tracking and AI algorithms for customized corneal correction.泉州爱尔眼科医院发布‘全光塑’个性化近视矫正技术，采用光迹追踪和AI算法进行定制化角膜矫正。
2024-12-10Loudi Aier Eye Hospital introduced 'QuanGuangSu' (Whole-Light Sculpting) myopia correction technology based on real-eye 3D model and AI algorithm.娄底爱尔眼科医院引入基于真实眼3D模型和AI算法的“全光塑”近视矫正技术。
2025-04-21Aier Eye Hospital and Alcon (China) signed a strategic cooperation agreement to promote the 'All-Light Sculpture' (全光塑) technology across 100 Aier hospitals, advancing refractive surgery standardization.爱尔眼科与爱尔康（中国）签署深度战略合作协议，推动全光塑技术在100家爱尔医院落地，推进屈光手术标准化。
2025-05-12Aier Eye Hospital Chongqing region established the first 'All-Optical Sculpture' (QuanGuangSu) myopia surgery center, and signed a strategic cooperation agreement with Alcon China to promote the technology across 100 hospitals.爱尔眼科重庆特区成立首家“全光塑”近视手术中心，并与爱尔康（中国）签署深度战略合作协议，推动全光塑技术在100家医院落地。
2025-06-18Dali Aier Eye Hospital held a refractive surgery technology upgrade conference, introducing new customized procedures integrating whole-eye data and AI modeling; awarded 'QuanGuangSu Leading Cooperation Unit' and established 'Zhou Qizhi Doctoral Workstation'.大理爱尔眼科医院举办近视手术技术升级发布会，引入整合全眼数据采集与AI智能建模的个性化矫正技术；被授予“全光塑领航合作单位”，并揭牌“周奇志博导工作站”。
2026-06-18Deyang Aier Eye Hospital introduced the 'QuanGuangSu' (All-Light Sculpting) personalized refractive correction technology, achieving full coverage of refractive surgery types.德阳爱尔眼科医院引进“全光塑”个性化屈光矫正技术，实现屈光全术式全面覆盖。
Bribery & kickback allegations贿赂与回扣指控
3 · 2024-01-05 → 2024-12-10
▾
Whistleblower allegations and regulatory probes into bribery of public officials, school principals, and referring doctors.举报人和监管机构对向公职人员、校长、转诊医生行贿的指控和调查。
2024-01-05Whistleblower Ai Fen alleged that Guigang Aier Eye Hospital engaged in widespread bribery of public officials; the hospital denied the claims.爆料人艾芬指控贵港爱尔眼科医院大范围行贿公务人员；院方否认。
2024-01-22Aier Eye Hospital denied allegations that Guilin Aier Eye Hospital paid kickbacks to primary school principals for referring students; the hospital is cooperating with police investigation.爱尔眼科否认桂林爱尔眼科医院向小学校长支付回扣推荐学生的指控；医院正配合警方调查。
2024-12-10Xuchang Aier Eye Hospital was investigated by the market regulator for allegedly giving kickbacks to referring doctors; 3 of 7 contacted doctors confirmed receiving payments.许昌爱尔眼科医院被指给转诊医生提成，许昌市市场监督管理局立案调查，7名医生中3人承认收到提成。
Regulatory penalties & compliance fines监管处罚与合规罚款
21 · 2024-01-08 → 2026-06-01
▾
Numerous Aier hospitals fined for violations including unlicensed practice, improper advertising, bribery, and medical insurance fraud.多家爱尔医院因无证执业、违规广告、商业贿赂、医保违规等被罚款。
2024-01-08Xiangyang Aier Eye Hospital was fined 5,000 yuan by the Xiangyang Health Commission for reusing disposable medical devices and failing to comply with disinfection standards.襄阳爱尔眼科医院因重复使用一次性医疗器具、消毒违规被襄阳市卫健委罚款5000元。
2024-02-20Guilin Aier Eye Hospital was fined 100,000 yuan by the Guilin Health Commission for conducting free clinic activities without filing and allowing unlicensed graduates to perform cataract screenings.桂林爱尔眼科医院因未经备案擅自开展义诊活动、安排无证毕业生进行白内障筛查，被桂林市卫健委罚款10万元。
2024-02-26Jinan Aier Eye Hospital, a wholly-owned subsidiary, was fined 50,000 yuan by the Jinan市中区 Health Bureau for practicing without a medical institution license, violating the Basic Healthcare and Health Promotion Law.爱尔眼科全资子公司济南爱尔眼科医院因未取得医疗机构执业许可证擅自执业，被济南市市中区卫健局罚款5万元。
2024-02-27Jinan Aier Eye Hospital was also fined 10,000 yuan by the Jinan Licheng District Market Supervision Bureau on Feb 7, 2024, for publishing illegal medical advertisements, marking two violations within one month.济南爱尔眼科医院于2024年2月7日因发布违法医疗广告被济南市历城区市场监管局罚款1万元，一个月内两次违规。
2024-04-01Three Aier Eye Hospital subsidiaries fined for regulatory violations: Huzhou Zhili Aier Eye Hospital fined 11,000 yuan for improper medical record keeping; Qianxinan Aier Eye Hospital fined 12,000 yuan for failing to inform patients of anesthesia methods and risks; Huzhou Aier Eye Hospital fined 10,000 yuan for employing unlicensed medical staff.爱尔眼科三家子公司因违规被罚：湖州织里爱尔眼科门诊部因病历管理不当被罚1.1万元；黔西南爱尔眼科医院因未告知麻醉方式和风险被罚1.2万元；湖州爱尔眼科医院因使用非卫生技术人员被罚1万元。
2024-04-19Yulin Aier Eye Hospital was fined 130,000 yuan by the Guangxi Administration for Market Regulation for publishing unapproved medical ads containing efficacy and safety claims for ICL surgery.玉林爱尔眼科医院因发布未经审查的ICL手术医疗广告，含功效和安全性断言，被广西市场监管局罚款13万元。
2024-04-29Pingnan Aier Eye Hospital was fined 37,000 yuan by the Guigang Health Commission for employing an unlicensed technician to perform ophthalmic examinations.平南爱尔眼科医院因使用非卫生技术人员从事眼科检查工作，被贵港市卫生健康委员会罚款3.7万元。
2024-05-24Xianning Aier Eye Hospital was fined over 35,000 yuan by Xian'an District Medical Security Bureau for overcharging, undocumented charges, duplicate billing, and violating medical practices, and ordered to return 23,000 yuan of medical insurance funds.咸宁爱尔眼科医院因超标准收费、无记录收费、重复收费、违反诊疗常规等被咸安区医疗保障局罚款3.5万余元，退回医保基金损失2.3万余元。
2024-05-27Wuxi Aier Eye Hospital was fined 200,000 yuan and had 31,900 yuan of illegal income confiscated by Wuxi Market Supervision Bureau for commercial bribery.无锡爱尔眼科医院因商业贿赂被无锡市市场监督管理局罚款20万元，没收违法所得3.19万余元。
2024-06-11Jinan Aier Eye Hospital was fined 50,000 yuan by Jinan Shizhong District Health Bureau for unauthorized charity clinic activities, and 2,000 yuan for violating disinfection regulations.济南爱尔眼科医院因擅自开展义诊活动被济南市市中区卫健局罚款5万元，因消毒违规被罚2000元。
2024-09-02Dali Aier Eye Hospital fined 50,000 yuan by Dali Health Bureau for conducting free clinic without filing.大理爱尔眼科医院因未经备案擅自开展义诊活动，被大理市卫生健康局罚款5万元。
2024-10-10Shanghai Aier Eye Hospital Co., Ltd. was fined 50,000 yuan by the Shanghai Chongming District Health Commission for conducting unregistered charity clinics without a medical institution license.上海爱尔眼科医院有限公司因未经备案擅自开展义诊活动，被上海市崇明区卫生健康委员会罚款5万元。
2024-12-18Shanghai Aier Qingliang Eye Hospital was fined by Qingpu Health Commission for organizing a free clinic without prior备案 (filing) with health authorities.上海爱尔清亮眼科医院因未经卫生行政部门备案擅自组织义诊活动，被青浦卫健委行政处罚。
2025-01-19Guigang Aier Eye Hospital was penalized by the Guangxi Market Supervision Bureau for publishing medical advertisements inconsistent with the approved content, violating the Medical Advertising Management Measures.贵港爱尔眼科医院因发布与《医疗广告审查证明》核准内容不一致的广告，被广西市场监管局查处并列为典型案例。
2025-07-16Xuchang Aier Eye Hospital fined over 190,000 yuan by Xuchang Market Supervision Bureau for bribery involving 181 patients and 79 referrers (village doctors, private hospital staff) from June 2022 to February 2023.许昌爱尔眼科医院因贿赂被许昌市市场监督管理局罚没超19万元，涉及181名患者和79名推荐人员（村医、民营医院工作人员），时间从2022年6月至2023年2月。
2026-01-23Lishui Aier Eye Hospital was fined 77,543.75 yuan and ordered to return 48,346.72 yuan for illegal medical insurance fund deductions (decomposed billing, duplicate charges).丽水爱尔眼科医院因分解收费、重复收费等造成医疗保障基金损失，被罚款77543.75元，并退回违规造成的基金损失48346.72元。
2026-01-26Hengzhou Aier Eye Hospital was fined 8,000 yuan by the Health Bureau for conducting free clinic activities without filing.横州爱尔眼科医院因未经备案开展义诊活动，被横州市卫生健康局罚款8000元。
2026-01-30Chongqing Fuling Aier Eye Hospital was fined 578.10 yuan and ordered to return 578.10 yuan for including non-reimbursable items (corneal endothelial examination, acupoint injection) in medical insurance settlement.重庆涪陵爱尔眼科医院因将不属于医保支付范围的角膜内皮镜检查、穴位注射纳入医保结算，被追回医保基金损失578.10元，并处1倍罚款578.10元。
2026-03-06Zunyi Aier Eye Hospital was fined 95,000 yuan by the health bureau for employing 5 unlicensed personnel to perform ophthalmic ultrasound tests from 2019 to 2025 and unauthorized prescription of antibiotics.遵义爱尔眼科医院因2019年至2025年间使用5名无资质人员操作眼科超声诊断仪及违规开具抗菌药物，被卫生健康局罚款9.5万元。
2026-05-20Aier Eye Hospital announced that after a self-inspection, it needs to pay back taxes of 348 million yuan and late fees of 176 million yuan, totaling 524 million yuan, and will increase its 2025 corporate income tax filing amount by 232 million yuan.爱尔眼科公告，经自查需补缴税款3.48亿元及滞纳金1.76亿元，合计5.24亿元，并增加2025年度企业所得税申报金额2.32亿元。
2026-06-01Aier Eye Hospital disclosed a tax self-inspection result: it needs to pay back taxes of 348 million yuan and a late fee of 176 million yuan, totaling 524 million yuan, all recorded in 2026 current-period profit or loss.爱尔眼科披露税务自查结果：需补缴税款3.48亿元及滞纳金1.76亿元，合计5.24亿元，全部计入2026年当期损益。
Business strategy & market outlook业务战略与市场展望
9 · 2024-01-11 → 2026-01-22
▾
Strategic growth drivers, market commentary, tariff impact, and business scope clarifications.战略增长驱动、市场评论、关税影响及业务范围澄清。
2024-01-11Aier Eye Hospital stated in an investor survey that it will continue to expand its medical network, focusing on county-level cities and same-city outpatient clinics and optometry centers.爱尔眼科在投资者调研中表示将持续完善医疗网络布局，重点覆盖县级市及同城门诊部和视光诊所。
2024-08-20Aier Eye Hospital stated it currently does not engage in AI glasses-related business; its optometry services mainly include medical eyewear like frames, lenses, and contact lenses.爱尔眼科表示目前不涉及AI眼镜相关业务，视光服务项目主要包括医学配镜业务如光学镜架、镜片和角膜接触镜等。
2024-11-21Aier Eye Hospital stated in an investor interaction that it has no plans to acquire other listed ophthalmology companies, focusing on organic development.爱尔眼科在投资者互动中表示，无意向并购其他眼科上市公司，专注于内生发展。
2025-04-07Aier Eye Hospital stated that the US tariff war has minimal short-term impact; US-origin drug procurement accounts for only 2.6% of total drug procurement, and US-origin equipment (cataract surgery devices, IOLs) has European and domestic alternatives.爱尔眼科表示关税战短期影响很小；原产于美国的药品采购金额仅占所有药品采购金额的2.6%，原产于美国的设备（白内障手术设备、人工晶体）有欧洲和国产替代品。
2025-04-08Aier Eye Hospital announced plans to increase procurement from domestic and non-US suppliers, sign long-term contracts to lock in prices, and gradually enter upstream supply chains to enhance self-reliance.爱尔眼科宣布计划增加国产及非美供应商采购比例、签订长期合同锁定价格，并逐步进入部分上游供应链以增强自主可控能力。
2025-05-07In 2024, the number of domestic hospitals increased from 256 to 352, and outpatient clinics from 183 to 229; the company explained that newly acquired hospitals are mostly county-level with short operating history and small revenue contribution.2024年境内医院从256家增至352家，门诊部从183家增至229家；公司解释新并购医院多为地县级医院，院龄短、收入体量小，且仅计入并表后收入。
2025-06-06Aier Eye Hospital Group launched the 'Post-Diagnosis Home Eye Health Management System' on National Eye Day, covering pediatric, youth myopia, refractive surgery, and geriatric eye disease management.爱尔眼科在全国爱眼日发布“诊后家庭眼健康管理体系”，涵盖小儿眼病、儿童青少年近视防控、中青年近视摘镜及中老年眼病诊疗。
2025-06-11Aier Eye Hospital identified presbyopia treatment and overseas M&A as new growth drivers, noting low domestic penetration and strong European subsidiary performance; also disclosed AI strategy to build 'Aier AI Eye Hospital'.爱尔眼科将老花治疗与海外并购定位为新增长曲线，指出国内老花手术普及率极低、欧洲子公司业务良好；同时披露人工智能战略，计划构建“爱尔AI眼科医院”。
2026-01-22Aier Eye Hospital disclosed plans to establish 'Aier Technology Industry Group' focusing on high-value consumables, medical equipment, biopharmaceuticals, and AI technology through investment, M&A, self-research, and cooperation.爱尔眼科披露计划成立“爱尔科技产业集团”，围绕高值耗材、医疗设备、生物制药、AI技术等核心赛道，采用投资、并购、自研、合作等方式打造眼健康产业链生态闭环。
Award & ranking recognition奖项与排名认可
15 · 2024-01-13 → 2026-04-15
▾
Aier received multiple awards including China New Economy Top 500, Hurun China 500, and ESG innovation awards.爱尔获得中国新经济500强、胡润中国500强、ESG创新奖等多个奖项。
2024-01-13Aier Eye Hospital ranked 43rd on the '2023 China New Economy Top 500 Enterprises' list, issued by the China Enterprise Evaluation Association.爱尔眼科入选“2023中国新经济企业500强”，位列第43名。
2024-01-16Aier Eye Hospital was awarded the 'Annual Enterprise Award' at the 18th People's Social Responsibility Awards by People's Daily Online for its CSR initiatives, including the 'Cross-Subsidy' charity model.爱尔眼科在第十八届人民企业社会责任奖中获得“年度企业奖”，因其“交叉补贴”公益模式等CSR举措。
2024-01-17Aier Eye Hospital was listed among the '2023 China Listed Company Value Top 100' by an unnamed organizer, recognizing its financial performance, governance, and innovation.爱尔眼科入选“2023年度中国上市公司价值榜”百强，表彰其财务表现、治理和创新。
2024-04-12Aier Eye Hospital won the 'Consumer Market Industry Influential Brand' award at the 18th China Consumer Economy High-Level Forum in Beijing, recognizing its innovation and digital economy development.爱尔眼科在北京第十八届中国消费经济高层论坛上荣获“消费市场行业影响力品牌”大奖，表彰其创新和数字经济发展。
2024-06-22Aier Eye Hospital won the 2024 'Future Health Industry Star Listed Company' award at the 2nd China Listed Company Industry Development Forum.爱尔眼科在第二届中国上市公司产业发展论坛获2024年度‘未来健康产业之星上市公司’奖。
2024-06-26Aier Eye Hospital received the 'Annual Charity Enterprise' award at the 2024 Charity Grand Ceremony for its contributions to rural revitalization and healthcare.爱尔眼科在2024慈善大典获‘年度慈善企业’奖，表彰其在乡村振兴和医疗健康方面的贡献。
2024-09-13Aier Eye Hospital won the 'Core Competitiveness ESG Comprehensive Governance Benchmark Enterprise' award at the 2024 CIFTIS China International Economic Management Technology Forum.爱尔眼科在2024服贸会·中国国际经济管理技术论坛上荣获“核心竞争力ESG综合治理标杆企业”奖。
2024-10-25Aier Eye Hospital was selected as a 'Model for Publicity and Recommendation on the 30th Anniversary of the Glorious Cause' at the national conference celebrating 30 years of the Glorious Cause, with Chairman Chen Bang attending the meeting.爱尔眼科医院集团在全国光彩事业发起实施30周年座谈会上被评选为“光彩30周年宣传推荐典型”，董事长陈邦受邀参会。
2024-12-04Aier Eye Hospital won the '2024 National Trusted Top 10 Health Brand' Golden Scepter Award at the 2024 Huaxia Big Health Industry Development Conference.爱尔眼科在2024华夏大健康产业发展大会上荣获金手杖奖“2024年度国民信赖十大健康品牌”。
2024-12-18Aier Eye Hospital won the 'Annual Responsible Practice ESG Innovation Pioneer' award at the 2024 Responsibility Practitioner Annual Conference.爱尔眼科在2024责任践行者年会上荣获“年度责任践行ESG创新先锋”奖。
2025-01-16Aier Eye Hospital Group won the 'Best Public Welfare Innovation Award' at the 2024 Excellent New Quality Productivity Enterprises and ESG Development Conference for its public welfare strategy and digital upgrade of eye health services.爱尔眼科医院集团在“2024优秀新质生产力企业暨ESG发展大会”上荣获“最佳公益创新奖”。
2025-02-25Aier Eye Hospital ranked on the Hurun China 500 list for the 6th consecutive year, as published by the Hurun Research Institute.胡润研究院发布《2024胡润中国500强》，爱尔眼科连续6年上榜。
2025-05-14Aier Eye Hospital was selected into S&P Global's 'Sustainability Yearbook (China Edition) 2025' for the first time, being one of only 4 healthcare companies recognized.爱尔眼科首次入选标普全球《可持续发展年鉴（中国版）2025》，是医疗保健行业仅有的4家上榜企业之一。
2025-10-17Aier Eye Hospital Group was listed in the 2025 Digital Economy Enterprise TOP 500, ranking 385th, jointly released by the China Enterprise Evaluation Association and the China Academy of Information and Communications Technology.爱尔眼科医院集团入选2025数字经济企业TOP500榜单，位列第385位，该榜单由中国企业评价协会与中国信息通信研究院联合发布。
2026-04-15Aier Eye Hospital ranked 69th on the '2025 China New Economy Enterprise TOP 500' list, up 4 places from last year.爱尔眼科位列'2025中国新经济企业500强'第69位，较去年提升4位。
Share pledge & controlling shareholder actions股份质押与控股股东行动
9 · 2024-01-15 → 2026-06-23
▾
Controlling shareholder Chen Bang extended and adjusted share pledges, with no risk of forced liquidation.控股股东陈邦多次延期和调整股份质押，无强制平仓风险。
2024-01-15Aier Eye Hospital's actual controller Chen Bang extended the pledge of approximately 216 million shares (14.97% of his holdings); no risk of forced liquidation or change of control.爱尔眼科实际控制人陈邦办理了约2.16亿股（占其所持股份14.97%）的质押展期；无平仓或控制权变更风险。
2024-02-20Aier Eye Hospital's controlling shareholder, Aier Medical Investment Group, pledged 30 million shares (0.32% of total equity) to Bank of Changsha, with cumulative pledged shares reaching about 323 million (10.08% of its holdings).爱尔眼科控股股东爱尔医疗投资集团向长沙银行质押3000万股（占总股本0.32%），累计质押约3.23亿股（占其持股10.08%）。
2024-10-28Controlling shareholder Chen Bang pledged 183 million shares (1.96% of total equity) to Huatai Securities (Shanghai) Asset Management Co., Ltd.控股股东陈邦向华泰证券（上海）资产管理有限公司合计质押1.83亿股，占总股本1.96%。
2024-11-08Actual controller Chen Bang pledged 50 million shares (0.54% of total) to Shanghai Haitong Securities Asset Management for a stock pledge repo, and released 37 million shares from pledge with CITIC Securities.实际控制人陈邦向上海海通证券资产管理有限公司质押5000万股（占总股本0.54%），并解除了与中信证券的3700万股质押。
2025-08-04Controlling shareholder Chen Bang pledged 139 million shares (9.63% of his holdings) and released 183 million shares from pledge.实际控制人陈邦质押1.39亿股（占其持股9.63%），并解除质押1.83亿股。
2025-10-17Aier Eye Hospital Group's controlling shareholder, Aier Medical Investment Group, pledged 145 million shares (1.55% of total share capital) to China CITIC Bank on October 16, 2025, with a maturity date of September 29, 2028.爱尔眼科医院集团控股股东爱尔医疗投资集团有限公司于2025年10月16日将其持有的1.45亿股（占总股本1.55%）质押给中信银行股份有限公司，质押到期日为2028年9月29日。
2026-01-22Aier Eye Hospital's actual controller Chen Bang pledged 62 million shares (4.29% of his holdings) to Guotai Junan Securities for a stock pledge repo transaction, starting January 20, 2026, ending January 19, 2027.爱尔眼科实际控制人陈邦将其持有的6200万股股份（占其所持股份4.29%）质押给国泰君安证券进行股票质押式回购交易，质押起始日2026年1月20日，到期日2027年1月19日。
2026-03-16Controlling shareholder Aier Medical Investment Group released 109.49 million shares from pledge on March 13, reducing pledged shares to 19.09% of its holdings.控股股东爱尔医疗投资集团于3月13日解除质押1.0949亿股，累计质押股份降至其持股的19.09%。
2026-06-23Aier Eye Hospital's actual controller Chen Bang pledged an additional 14 million shares as a supplementary pledge to Guotai Haitong Securities.爱尔眼科实际控制人陈邦将其所持1400万股股份办理补充质押，质权人为国泰海通证券。
Expert workstation & talent recruitment专家工作站与人才引进
10 · 2024-01-20 → 2026-04-29
▾
Aier established multiple expert workstations and recruited renowned ophthalmologists to enhance clinical capabilities.爱尔设立多个专家工作站，引进知名眼科专家以提升临床能力。
2024-01-20Aier Eye Hospital Yunnan Province Chief Expert Jiang Chunguang's workstation was inaugurated at Dali Aier Eye Hospital, focusing on adolescent myopia prevention and control.爱尔眼科云南省区总院长江春光博士工作站在大理爱尔眼科医院揭牌，专注青少年近视防控。
2024-04-13Han Fang Doctoral Workstation was established at Dali Aier Eye Hospital, aiming to enhance glaucoma diagnosis and treatment through expert consultations, surgeries, and training.“韩芳博士工作站”落户大理爱尔眼科医院，旨在通过专家坐诊、手术示教和培训提升青光眼诊疗水平。
2024-04-28Fan Chuanfeng Doctoral Workstation for fundus diseases was inaugurated at the 8th Aier Eye Hospital Taishan Summit Forum in Tai'an, focusing on diabetic retinopathy and academic exchange.在泰安第八届爱尔眼科泰山高峰论坛上，范传峰博士眼底病工作站正式揭牌，聚焦糖尿病视网膜病变和学术交流。
2024-08-30Renowned cataract expert Professor Han Yu joined Aier Eye Hospital as Vice President of Sichuan Province, aiming to enhance clinical training and surgical quality across 28 hospitals in the province.著名白内障专家韩宇教授加盟爱尔眼科，出任四川省区副总院长，旨在提升省内28家医院的临床培训和手术质量。
2025-01-05Professor Li Guixiang, a renowned ophthalmologist with over 30 years of experience, officially joined Aier Eye Hospital Group as the president of the Dali-Lijiang region in Yunnan Province.知名眼科专家李桂香教授正式加入爱尔眼科医院集团，担任云南省区大理丽江区院长。
2025-01-15The 'Dr. Han Fang Expert Team Workstation' was officially established at Qujing Aier Eye Hospital in Yunnan, aiming to improve ophthalmic diagnosis and treatment through technical exchanges and training.“韩芳博士专家团队工作站”正式落户云南曲靖爱尔眼科医院，旨在通过技术交流和培训提升眼科诊疗水平。
2025-01-24Professor Hu Yuntao, a heavyweight ophthalmologist, was appointed as the chief expert of Aier Eye Hospital Group's Shanghai region, aiming to build an international ophthalmic medical center.重量级眼科专家胡运韬教授出任爱尔眼科医院集团上海地区首席专家，旨在打造国际化眼科医学中心。
2025-05-19'Dr. Yang Fang Workstation' was inaugurated at Dali Aier Eye Hospital, bringing provincial-level refractive surgery resources to western Yunnan through a touring expert mechanism.“杨芳博士工作站”在大理爱尔眼科医院揭牌，通过博士专家团巡诊机制将省级屈光手术资源下沉至滇西。
2025-09-04International renowned ophthalmologist Wang Mingxu (prototype of Hollywood film 'SIGHT'), a dual PhD from Harvard University and MIT, awarded Aier Eye Hospital's Xiangtan, Yueyang, Yiyang, and Yongzhou districts the 'Refractive International Expert Work Guidance Station' plaque, marking the international alignment of refractive diagnosis and treatment technology in the Xiangtan region.国际著名眼科专家王明旭（好莱坞电影《光明》主人公原型）为爱尔眼科岳阳、湘潭、益阳、永州四区授予“屈光国际专家工作指导站”牌匾，标志着湘潭地区屈光诊疗技术正式与国际接轨。
2026-04-29Aier Eye Hospital's refractive surgery academic leader Professor Wang Zheng was named to the '2026 Global Ophthalmology Power List 50'.爱尔眼科屈光手术学组学科带头人王铮教授入选'2026年全球眼科最具影响力50强'榜单。
New subsidiary & hospital establishment新子公司与医院设立
16 · 2024-01-23 → 2026-06-23
▾
Aier established new subsidiaries and hospitals including IoT tech firms, optometry hospitals, and regional clinics.爱尔设立新的子公司和医院，包括物联网科技公司、视光医院和区域诊所。
2024-01-23Aier Eye Hospital co-founded Changsha Kaier You Technology Co., Ltd. with a registered capital of 1 million yuan, focusing on IoT technology and system integration services.爱尔眼科与湖南爱尔眼视光研究所等共同成立长沙凯尔优科技有限公司，注册资本100万元，主营物联网技术服务。
2024-08-21Chengdu Chengbei Aier Eye Hospital Co., Ltd. was established with registered capital of 30 million yuan, jointly held by Aier Eye Hospital and Chengdu Shirui Medical Management Center.成都城北爱尔眼科医院有限公司成立，注册资本3000万元，由爱尔眼科和成都视瑞医疗管理中心共同持股。
2025-02-18Aier Eye Hospital fully funded Hainan Kangmujia Pharmaceutical Co., Ltd. with a registered capital of 10 million yuan, covering pharmaceutical wholesale, medical device internet services, and supply chain management.爱尔眼科出资1000万元全资成立海南康目佳医药有限责任公司，经营范围包括药品批发、医疗器械互联网信息服务、供应链管理等。
2025-03-06Shenzhen Binhai Aier Eye Hospital was established with a registered capital of 260 million yuan, wholly owned by Aier Eye Hospital, covering medical services and drug clinical trials.深圳滨海爱尔眼科医院成立，注册资本2.6亿元，由爱尔眼科全资持股，经营范围包括医疗服务及药物临床试验服务。
2025-06-24Aier Eye Hospital Group wholly funded and established Shijiazhuang Aier Optometry Eye Hospital Co., Ltd. with a registered capital of 22.1 million RMB, operating in medical services.爱尔眼科医院集团出资2210万元全资成立石家庄爱尔视光眼科医院有限责任公司，所属行业为卫生，经营范围包括医疗服务。
2026-01-30Aier Eye Hospital invested 85% in Wuhu Aier Eye Hospital Co., Ltd., with a registered capital of 30 million yuan, expanding its hospital network.爱尔眼科新增对外投资，投资芜湖爱尔眼科医院有限公司，占比85%，注册资本3000万元。
2026-02-28Aier Eye Hospital made a new outward investment, establishing Lianyungang Aier Eye Hospital Co., Ltd. with a 70% stake and registered capital of 30 million RMB; legal representative is He Weiliang.爱尔眼科新增对外投资，成立连云港爱尔眼科医院有限公司，持股70%，注册资本3000万元人民币，法定代表人为何伟亮。
2026-03-06Aier Eye Hospital invested in Zhongshan Xiaolan Aier Eye Hospital Co., Ltd. with a 53.33% stake and a registered capital of 30 million yuan.爱尔眼科对外投资中山小榄爱尔眼科医院有限公司，持股53.33%，注册资本3000万元。
2026-03-16Aier Eye Hospital invested in Chengdu Jishi Hulian Technology Co., Ltd. with a 99% stake and a registered capital of 10 million yuan, focusing on software and IT services.爱尔眼科对外投资成都极视互联科技有限公司，持股99%，注册资本1000万元，从事软件和信息技术服务业。
2026-03-21Aier Eye Hospital invested in Luoyang Boai Eye Hospital Co., Ltd. with a 60% stake and a registered capital of 40 million yuan.爱尔眼科对外投资洛阳博爱眼科医院有限公司，持股60%，注册资本4000万元。
2026-03-27Aier Eye Hospital invested in Jianli Aier Eye Hospital Co., Ltd. with a 70% stake and a registered capital of 9 million yuan.爱尔眼科对外投资监利爱尔眼科医院有限公司，持股70%，注册资本900万元。
2026-05-05Aier Eye Hospital invested in Yulin Aier Eye Hospital Co., Ltd., holding a 70% stake with a registered capital of 25 million yuan.爱尔眼科投资榆林爱尔眼科医院有限责任公司，持股70%，注册资本2500万元。
2026-05-10Aier Eye Hospital invested in Xiangxiang Aier Eye Hospital Co., Ltd., holding a 25% stake with a registered capital of 7.5 million yuan.爱尔眼科投资湘乡爱尔眼科医院有限公司，持股25%，注册资本750万元。
2026-05-14Aier Eye Hospital invested in Tongliao Aier Sheng'an Eye Hospital Co., Ltd., holding a 75.22% stake with a registered capital of 16.95 million yuan.爱尔眼科投资通辽爱尔圣安眼科医院有限责任公司，持股75.22%，注册资本1695万元。
2026-05-18Aier Eye Hospital invested in Pingnan Aier Eye Hospital Co., Ltd., holding a 70% stake with a registered capital of 11 million yuan.爱尔眼科投资平南爱尔眼科医院有限公司，持股70%，注册资本1100万元。
2026-06-23Aier Eye Hospital added an investment in Chongqing Hechuan Aier Eye Hospital Co., Ltd., with a 6.44% stake and registered capital of 35.7 million yuan.爱尔眼科新增对外投资，投资重庆合川爱尔眼科医院有限公司，持股6.44%，注册资本3570万元。
Digital health & remote consultation platform数字医疗与远程会诊平台
6 · 2024-01-30 → 2026-06-05
▾
Aier launched remote medical consultation centers, difficult eye disease platforms, and telemedicine networks connecting grassroots hospitals.爱尔推出远程医疗会诊中心、疑难眼病平台及连接基层医院的远程医疗网络。
2024-01-30Chongqing Aier Eye Hospital launched a 'Remote Medical Consultation Center' connecting 21 Aier hospitals in Chongqing to enable 'grassroots diagnosis, remote diagnosis' model.重庆爱尔眼科医院启用“远程医疗会诊中心”，连接重庆21家爱尔医院，实现“基层检查，远程诊断”模式。
2024-06-20Aier Eye Hospital launched a self-developed remote consultation platform for difficult eye diseases, enabling 'cloud consultation' from Changsha Medical Center to Xinjiang patients.爱尔眼科自主研发的疑难眼病远程会诊平台上线，实现长沙医学中心对新疆患者的‘云端会诊’。
2025-05-28Aier Eye Hospital Beijing region launched a remote medical consultation center, connecting expert resources with grassroots hospitals nationwide, covering 8 sub-specialties including cornea, fundus, glaucoma, cataract, and refractive surgery.爱尔眼科北京区远程医疗会诊中心启用，将专家资源与全国基层医院无缝连接，涵盖眼表角膜、眼底病、青光眼、白内障、屈光等八大亚专科。
2025-08-26Semi-annual report disclosed: established a presbyopia management MTD group and plans to open presbyopia clinics; remote medical center now covers 20+ provinces with 200,000+ remote readings in H1.半年报披露：成立老视管理MTD学组并计划开设老视门诊；远程医疗中心覆盖20余省，上半年完成远程阅片20余万例。
2026-03-27Aier Eye Hospital opened a green referral channel to Hong Kong for fundus disease patients, enabling photodynamic therapy (PDT) within 3 days, and leveraging Hainan Boao's pilot policy for advanced treatments.爱尔眼科为眼底病患者开设香港绿色转诊通道，3天内完成光动力治疗，并利用海南博鳌先行先试政策开展先进治疗。
2026-06-05Fuzhou Aier Eye Hospital successfully helped two patients travel to Hong Kong for photodynamic therapy (PDT) for macular disease, utilizing the group's global medical network.福州爱尔眼科依托集团全球化布局，成功帮助两名患者赴港接受黄斑病变光动力治疗（PDT）。
Zeiss partnership & full femtosecond 4.0/SMILE pro technology蔡司合作与全飞秒4.0/SMILE pro技术
21 · 2024-01-30 → 2026-06-13
▾
Aier partnered with Zeiss to introduce minimally invasive full femtosecond 4.0-VISULYZE and robot-assisted SMILE pro systems across hospitals.爱尔与蔡司合作，在多家医院引入微创全飞秒4.0-VISULYZE和机器人辅助SMILE pro系统。
2024-01-30Aier Eye Hospital and Carl Zeiss jointly inaugurated the 'Aier Refractive Clinical Cooperation and Exchange Station' in the Boao Lecheng International Medical Tourism Pilot Zone to introduce global ophthalmic technologies.爱尔眼科与卡尔蔡司在博鳌乐城先行区共同为“爱尔屈光临床合作交流站”揭幕，引入国际眼科技术。
2024-03-12Suqian Aier Eye Hospital held a launch ceremony for Zeiss全飞秒 (ReLEx SMILE) equipment, becoming the only hospital in Suqian offering all corneal refractive surgery modalities (femtosecond, LASIK, TransPRK, ICL).宿迁爱尔眼科医院举行蔡司全飞秒设备开机仪式，成为宿迁市唯一一家全术式角膜屈光手术医院（飞秒、个性化飞秒、全激光、ICL）。
2024-07-17Nanjing Aier Eye Hospital became the first batch in China to launch minimally invasive full femtosecond precision 4.0-VISULYZE technology, designated as a clinical cooperation unit by Zeiss.南京爱尔眼科医院成为全国首批、南京首发落地微创全飞秒精准4.0-VISULYZE技术的专业近视手术机构，被蔡司公司授予临床合作单位。
2024-07-23Chengdu Aier Eye Hospital introduced and installed the minimally invasive full femtosecond precision 4.0-VISULYZE system, marking the entry into the 4.0 era for minimally invasive full femtosecond surgery.成都爱尔眼科医院引入微创全飞秒精准4.0-VISULYZE系统并装机启用，标志着该院微创全飞秒迈入4.0时代。
2024-09-28Changsha Aier Eye Hospital became one of the first clinical cooperation units in Hunan for Carl Zeiss' minimally invasive full femtosecond precision 4.0-VISULYZE technology.长沙爱尔眼科医院成为湖南首批卡尔蔡司微创全飞秒精准4.0-VISULYZE临床合作单位。
2024-11-04Nanning Aier Eye Hospital launched the 'Full Femtosecond 4.0 VISULYZE' technology, an upgrade from SMILE 3.0, and opened its high-end brand Nanning Aier Xiyou Eye Clinic.南宁爱尔眼科医院发布了‘全飞秒4.0 VISULYZE’技术（SMILE 3.0的升级版），并开业了其高端品牌南宁爱尔西柚眼科门诊部。
2024-12-05Liaoning Aier Eye Hospital installed the Zeiss VisuMax 4.0-VISULYZE system for minimally invasive SMILE surgery, upgrading from 3.0 to 4.0 for higher precision.辽宁爱尔眼科医院装机启用蔡司微创全飞秒精准4.0-VISULYZE系统，从3.0升级至4.0版本，提升精准度和安全性。
2025-01-10Hengshui Aier Eye Hospital introduced the Zeiss minimally invasive full femtosecond precision 4.0-VISULYZE system and was awarded 'Zeiss Minimally Invasive Full Femtosecond Precision 4.0-VISULYZE Clinical Cooperation Unit'.衡水爱尔眼科医院引进德国蔡司微创全飞秒精准4.0-VISULYZE系统，并被授予“蔡司微创全飞秒精准4.0-VISULYZE临床合作单位”称号。
2025-02-15Fuzhou Aier Eye Hospital held the launch event for minimally invasive full femtosecond precision 4.0-VISULYZE, upgrading its refractive surgery technology to a new generation.福州爱尔眼科医院举办微创全飞秒精准4.0-VISULYZE发布会，屈光手术技术升级至新一代。
2025-03-15Kunming Aier Eye Hospital announced that four doctors received certification for 'Minimally Invasive Full-Femtosecond Precision 4.0-VISULYZE Surgery', becoming one of the first hospitals in Yunnan to offer this upgraded procedure.昆明爱尔眼科医院宣布4名医生获得“微创全飞秒精准4.0-VISULYZE手术认证医师”资格，成为云南首批开展该升级术式的医院。
2025-04-02Qujing Aier Eye Hospital held a launch event for the minimally invasive SMILE 4.0-VISULYZE technology upgrade, entering the personalized correction 4.0 system era.曲靖爱尔眼科医院举办微创全飞秒精准4.0-VISULYZE技术升级发布会，进入个性化矫正4.0系统时代。
2025-05-19Chongqing Aier Eye Hospital (headquarters) launched the new-generation robot-assisted 'Full Femtosecond Pro' (SMILE pro) myopia surgery using the Zeiss VISUMAX 800, achieving 10-second lenticule extraction.重庆爱尔眼科医院（总院）发布新一代机器人全飞秒Pro近视手术，采用蔡司VISUMAX 800设备，实现10秒极速扫描。
2025-05-31Xiangyang Aier Eye Hospital (Hubei) installed the first new-generation robot-assisted full femtosecond VISUMAX 800 and SMILE pro system in the city, enabling 10-second lenticule creation.襄阳爱尔眼科医院引进全国首批、襄阳首台新一代机器人全飞秒VISUMAX 800及SMILE pro系统，实现10秒内完成单眼透镜制作。
2025-06-28Kunming Aier Eye Hospital launched the new-generation robotic whole femtosecond SMILE pro procedure, reducing single-eye lens scanning to under 10 seconds, marking entry into the '10-second precision minimally invasive era' in Yunnan.昆明爱尔眼科医院举行新一代机器人全飞秒授牌暨新微创全飞秒SMILE pro启动仪式，单眼透镜扫描时间缩短至10秒内，宣告云南省区近视手术迈入“10秒级精准微创时代”。
2025-08-25Installed the first domestic medical-institution dedicated training unit of the new-generation robot femtosecond laser VISUMAX 800 at the Aier International Clinical Training Center.新一代机器人全飞秒VISUMAX 800在爱尔眼科国际临床培训中心完成装机，为国内首台医疗机构专用培训机。
2025-08-26Semi-annual report disclosed: outpatient visits reached 9.2483 million (+16.47% YoY); introduced Zeiss VISUMAX 800 and launched SMILEpro surgery.半年报披露：门诊量达924.83万人次（同比+16.47%）；引进蔡司VISUMAX 800并推出SMILEpro手术。
2026-01-12Aier Eye Hospital Group achieved 10,000 SMILE Pro surgeries, receiving the 'China Ophthalmic Hospital Group Breakthrough Contribution Award' at the SMILE Pro High-Quality Development Forum; China's total SMILE Pro surgeries exceeded 40,000 cases.爱尔眼科医院集团累计完成1万例SMILE Pro手术，在SMILE Pro高质量发展论坛上获颁“中国眼科医院集团突破贡献奖”；中国SMILE Pro手术总量突破4万例。
2026-01-28Aier Eye Hospital Guangxi introduced the first German Zeiss VISUMAX 800 femtosecond laser equipment, becoming the only ophthalmic institution in Guangxi capable of performing the full SMILE series (3.0, 4.0, Pro).广西爱尔首台德国蔡司VISUMAX 800全飞秒激光设备落户南宁爱尔眼科医院，使其成为广西唯一能开展全飞秒SMILE 3.0、4.0及Pro全系列术式的眼科机构。
2026-03-23Shanghai Aier Eye Hospital held a launch event for the new-generation robot-assisted SMILEpro surgery, introducing advanced refractive technology.上海爱尔眼科医院举办新一代机器人全飞秒SMILEpro手术发布会，引入先进屈光技术。
2026-06-08Dongguan Aier Eye Hospital achieved a milestone of 800 cases of next-generation robot-assisted SMILE Pro femtosecond surgery.东莞爱尔眼科医院新一代机器人全飞秒SMILE Pro手术突破800例。
2026-06-13Aier Eye Hospital and ZEISS Medical signed a procurement agreement for 25 VISUMAX 800 robot femtosecond laser devices, upgrading their global strategic partnership.爱尔眼科与蔡司医疗签约采购25台VISUMAX 800机器人全飞秒设备，升级全球战略合作伙伴关系。
Goodwill & M&A fund expansion商誉与并购基金扩张
14 · 2024-02-01 → 2025-12-25
▾
Aier disclosed large goodwill balance and continued acquiring hospitals via M&A funds, acquiring 87 institutions in 2024.爱尔披露大额商誉余额，并通过并购基金持续收购医院，2024年收购87家机构。
2024-02-01Aier Eye Hospital disclosed that as of end-2023, it had 5.901 billion yuan in goodwill, nearly 30% of net assets, and continued expansion via M&A funds, acquiring 14 hospitals in Jan 2023 and 7 hospitals in Sep 2023.爱尔眼科披露截至2023年末商誉59.01亿元，占净资产近30%，并通过并购基金持续扩张，2023年1月收购14家医院，9月收购7家医院部分股权。
2024-05-31Aier Eye Hospital board approved acquisition of partial equity in 52 medical institutions (including Chongqing Yanshiguang, Zhoukou Aier) for 1.344 billion yuan in cash, to deepen the 'hierarchical chain' system.爱尔眼科董事会批准以13.44亿元自有资金收购重庆眼视光、周口爱尔等52家医疗机构部分股权，深化“分级连锁”体系。
2024-06-01Aier Eye Hospital announced a plan to acquire partial equity of 52 domestic medical institutions for a total of 1.344 billion yuan, deepening its 'hierarchical chain' system.爱尔眼科公告拟斥资13.44亿元收购52家境内医疗机构部分股权，深化‘分级连锁’体系。
2024-07-29Aier Eye Hospital announced the acquisition of partial equity in 35 hospitals (including Humen Aier, Yuncheng Aier, etc.) for a total of 898.466 million yuan in自有资金, to further expand its分级连锁 network.爱尔眼科公告拟以自有资金8.98亿元收购虎门爱尔、运城爱尔等35家医院部分股权，以完善分级连锁体系。
2024-08-01Aier Eye Hospital announced acquisition of partial equity in 35 hospitals including Humen Aier and Yuncheng Aier for a total consideration of 898 million yuan, funded by自有资金.爱尔眼科宣布收购虎门爱尔、运城爱尔等35家医院部分股权，合计对价8.98亿元，以自有资金支付。
2024-08-01Aier Eye Hospital announced acquisition of partial equity in 52 medical institutions including Chongqing Yanshiguang and Zhoukou Aier for a total consideration of 1.344 billion yuan, completed in May 2024.爱尔眼科宣布收购重庆眼视光、周口爱尔等52家医疗机构部分股权，合计对价13.44亿元，于2024年5月完成。
2024-08-23Aier Eye Hospital stated that the 52 medical institutions acquired in 2024 were consolidated into the financial statements starting June, contributing total revenue of 115 million yuan for the period.爱尔眼科表示，2024年收购的52家医疗机构于6月份纳入并表范围，本期营业收入总计1.15亿元。
2024-09-03Aier Eye Hospital acquired partial equity of 35 hospitals including Humen Aier and Yuncheng Aier for about 898 million yuan.爱尔眼科以约8.98亿元收购虎门爱尔、运城爱尔等35家医院部分股权。
2024-11-02Aier Eye Hospital announced acquisition of partial equity in 52 medical institutions (including Chongqing Yanguang, Zhoukou Aier) for RMB 1.344 billion, approved on May 31, 2024.爱尔眼科宣布收购52家医疗机构（包括重庆眼视光、周口爱尔等）部分股权，交易金额13.44亿元，于2024年5月31日审议通过。
2024-11-02Aier Eye Hospital announced acquisition of partial equity in 35 hospitals (including Humen Aier, Yuncheng Aier) for approximately RMB 898 million, approved on July 29, 2024.爱尔眼科宣布收购35家医院（包括虎门爱尔、运城爱尔等）部分股权，交易金额约8.98亿元，于2024年7月29日审议通过。
2025-05-21Chairman Chen Bang indicated at the AGM that the M&A fund model has largely completed its historical mission, and future growth will focus on endogenous improvement of existing hospitals, with over 200 hospitals undergoing transformation and upgrade.董事长陈邦在股东大会上表示，产业并购基金模式基本完成历史使命，未来将聚焦现有医院的内生增长，200余家医院迎来转型升级。
2025-08-29Board of directors approved the acquisition of partial equity in three medical institutions: Tongren Aier, Taojiang Aier, and Mudanjiang Aier Focus Ophthalmology Clinic, for a total of 105 million yuan in self-owned funds.董事会审议通过收购铜仁爱尔、桃江爱尔、牡丹江爱尔焦点眼科门诊部3家医疗机构部分股权，合计1.05亿元自有资金。
2025-12-24Aier Eye Hospital's board approved the acquisition of partial equity in 39 institutions including Bozhou Aier and Lianyungang Aier for a total of RMB 963 million (approx. US$132 million), paid with自有资金 (own funds), to strengthen its tiered chain system.爱尔眼科董事会批准收购亳州爱尔、连云港爱尔等39家机构部分股权，交易合计金额9.63亿元，以自有资金支付，旨在完善分级连锁体系。
2025-12-25Aier Eye Hospital disclosed that the 39 acquired institutions had total revenue of RMB 685.9 million and net loss of RMB 59.0 million in 2024; for Jan-Sep 2025, revenue was RMB 588 million with net profit of RMB 20.24 million, indicating a turnaround.爱尔眼科披露，本次收购的39家机构2024年整体收入6.86亿元、净利润-5,899.51万元；2025年1-9月收入5.88亿元、净利润2,024万元，已步入扭亏为盈拐点。
Government recognition & policy support政府表彰与政策支持
3 · 2024-02-06 → 2024-07-05
▾
Hunan provincial leaders and CCPIT president visited Aier, praising its global expansion and 'Oriental Eye Valley' project.湖南省领导及中国贸促会会长视察爱尔，赞扬其全球扩张和'东方眼谷'项目。
2024-02-06Hunan Provincial Government Deputy Secretary-General Chen Xianchun visited Aier Eye Hospital, toured its international clinical training center, and encouraged further international cooperation and the 'Oriental Eye Valley' eye health industrial park project.湖南省政府副秘书长陈献春走访爱尔眼科，参观国际临床培训中心，鼓励加强国际合作，推动“东方眼谷”眼健康产业园项目。
2024-02-08Hunan Provincial Party Secretary Shen Xiaoming and Governor Mao Weiming sent a Spring Festival慰问 letter to Aier Eye Hospital Chairman Chen Bang, praising the company's global expansion and its '1+8+N' strategy.湖南省委书记沈晓明、省长毛伟明向爱尔眼科董事长陈邦发来新春慰问信，肯定其全球扩张和“1+8+N”战略。
2024-07-05China Council for the Promotion of International Trade (CCPIT) President Ren Hongbin visited Aier Eye Hospital for investigation and research, discussing the company's 'going global' strategy and participation in the 2nd China International Supply Chain Expo.中国贸促会会长任鸿斌一行到爱尔眼科考察调研，就企业“走出去”、参与第二届链博会等议题进行交流。
Clinical technology & new procedures临床技术与新术式
14 · 2024-02-06 → 2026-06-25
▾
Introduction of new surgical technologies, devices, and treatment protocols across various ophthalmology subspecialties.在各眼科亚专科引入新手术技术、设备及治疗方案。
2024-02-06Aier Eye Hospital introduced a domestically produced scleral lens with fully independent intellectual property rights, offering new vision correction options for patients with irregular astigmatism and high refractive errors.爱尔眼科引进完全自主知识产权的国产化巩膜镜，为不规则散光和高度屈光不正患者提供新的屈光矫正选择。
2024-03-16Xiangyang Aier Eye Hospital introduced UCP (ultrasound cycloplasty) technology for glaucoma treatment, enabling non-incision, rapid intraocular pressure control.襄阳爱尔眼科医院引进青光眼治疗新技术UCP（超声睫状体成形术），实现无刀无创快速控制眼压。
2024-05-27Dali Aier Eye Hospital launched an 'Intraocular Injection Center' and 'One-stop Vitreous Injection Center' to streamline treatment for fundus diseases.大理爱尔眼科医院成立“眼内注药中心”和“一站式玻璃体腔注药中心”，优化眼底病诊疗流程。
2024-07-26Liaoning Aier Eye Hospital held a fundus disease forum, established a 'Floaters Clinic', and held the unveiling ceremony of the 'Ellex Laser Vitreolysis Clinical Demonstration Center'.辽宁爱尔眼科医院举办眼底病论坛，成立“飞蚊症门诊”，并举行“Ellex激光玻璃体消融临床示范中心”揭牌仪式。
2024-08-12Huiguang Aier Eye Hospital introduced the Alcon LenSx femtosecond laser cataract surgery system, marking entry into 'smart no-knife' cataract surgery era.惠光爱尔眼科医院引进爱尔康第三代金湛飞白设备LenSx，标志着白内障手术迈入‘智能无刀’新时代。
2024-10-25Aier Eye Hospital presented research on 'Tocilizumab in Refractory TAO' and 'Vitrectomy Combined with 48G Nano-Precision Needle for CRAO' at the first Yangtze River Delta Ophthalmology Innovation Conference.爱尔眼科在首届长三角眼科创新大会上展示了“托珠单抗在难治性TAO中的疗效观察”和“玻璃体切除联合48G纳米精微针治疗CRAO”等研究成果。
2024-12-11Loudi Aier Eye Hospital successfully performed a foldable capsular buckle (FCB) implantation, a new minimally invasive treatment for rhegmatogenous retinal detachment.娄底爱尔眼科医院成功开展折叠顶压球囊(FCB)植入术，用于孔源性视网膜脱离的微创治疗。
2024-12-29Quanzhou Aier Eye Hospital hosted the 4th Quanzhou ICL Surgery Standardization Training Course, a municipal continuing medical education program, with 50+ ophthalmologists.泉州爱尔眼科医院主办第四届泉州市ICL手术技巧规范化培训班，为市级继续医学教育项目，50余名眼科医生参与。
2025-06-11Aier Eye Hospital stated in an investor survey that since Q3 2024, refractive surgery average selling price has steadily recovered due to new procedures like QuanGuangSu and whole femtosecond 4.0, and price wars are receding.爱尔眼科在机构调研中表示，自2024年三季度起，得益于全光塑、全飞秒4.0等新术式推广，屈光手术客单价持续企稳回升，价格战正逐步退潮。
2025-06-25At the 'Aier Eye Hospital Fundus Disease Forum 2025 and 4th Yangtze River Delta Forum' in Shanghai, an eye trauma treatment consultation center was established, covering East China and radiating nationwide.在上海举行的“爱尔眼科眼底病论坛2025暨第四届长三角论坛”上，成立覆盖华东、辐射全国的眼外伤救治会诊中心。
2025-07-10Aier Eye Hospital held the 2025 Fundus Disease Forum (Chongqing), showcasing the world's first 48G ultra-fine needle for precise interventional thrombolysis in retinal artery occlusion and an ultrasonic microbubble targeted technology.爱尔眼科举办2025眼底病论坛（重庆站），展示了全球首款48G超微针头用于视网膜中央动脉阻塞精准介入溶栓，以及超声微泡靶向技术。
2025-07-24Fuzhou Aier Eye Hospital successfully performed the first penetrating Schlemm's canaloplasty (PCP) in Fuzhou, a minimally invasive glaucoma surgery, on a 30-year-old patient with secondary glaucoma.福州爱尔眼科医院成功施行福州首例穿透性Schlemm管成形术（PCP），一种青光眼微创手术，患者为一名30岁继发性青光眼男性。
2026-06-23Changde Aier Eye Hospital successfully performed the city's first femtosecond laser-assisted ICL surgery, marking a new breakthrough in refractive surgery in the region.常德爱尔眼科医院成功完成常德首例飞秒激光ICL近视矫正手术，实现屈光手术技术新突破。
2026-06-25Enshi Aier Eye Hospital completed its first batch of EVO+ ICL (V5) lens implant surgeries, marking the entry of the technology into the Enshi region.恩施爱尔眼科医院完成首批EVO+ ICL（V5）晶体植入手术，标志着该技术进入恩施地区。
R&D recognition & postdoctoral station研发认可与博士后工作站
3 · 2024-02-19 → 2026-01-30
▾
Aier's research center was recognized as a top R&D institution, and its postdoctoral station gained independent recruitment approval.爱尔研究中心获评顶尖研发机构，博士后工作站获批独立招收资格。
2024-02-19Aier Eye Hospital's Global Ophthalmology Medical Research Center was selected as one of Changsha's 2023 'Top 50 New R&D Institutions', and Chairman Chen Bang received the award at the city's high-quality development conference.爱尔全球眼科医学研究中心入选长沙市2023年度“新设研发机构50强”，董事长陈邦在全市高质量发展大会上接牌。
2024-03-22Aier Eye Hospital's postdoctoral research station received approval from the National Postdoctoral Management Office to independently recruit postdoctoral researchers, with a plan to recruit 400 postdocs and 100 mentors over 10 years.爱尔眼科博士后科研工作站获全国博士后管委会办公室批准可独立招收博士后研究人员，计划10年内引进培养400名博士后和100名导师。
2026-01-30Aier Eye Hospital received 35 project grants from the 2026 Hunan Provincial Natural Science Foundation (first batch), with the group's total provincial NSFC projects exceeding 100 in the past three years.爱尔眼科共35个项目获得2026年湖南省自然科学基金项目（第一批）立项资助，集团近三年获批省自然科学基金项目总数突破100项。
Frost & Sullivan market certification沙利文市场认证
1 · 2024-02-21
▾
Aier was certified as the world's largest in cumulative refractive surgery procedures by Frost & Sullivan.爱尔获沙利文认证为全球累计屈光手术量最大的眼科机构。
2024-02-21Aier Eye Hospital was certified by Frost & Sullivan as having the world's largest cumulative number of refractive surgery procedures (over 4.3 million cases) and China's leading refractive surgery volume, based on data from Jan 2022 to Jun 2023 across 816 authorized institutions.爱尔眼科获弗若斯特沙利文认证为全球屈光矫正手术完成量第一（累计超430万例）及中国屈光矫正手术量领先，基于2022年1月至2023年6月816家机构数据。
Capital market & shareholder returns资本市场与股东回报
13 · 2024-02-23 → 2026-04-08
▾
Events related to share buybacks, dividends, investor open days, shareholder benefits, and capital market communications.与股份回购、分红、投资者开放日、股东福利及资本市场沟通相关的事件。
2024-02-23Aier Eye Hospital's board secretary Wu Shijun suggested to CSRC Chairman Wu Qing that the tax calculation method for equity incentive restricted shares be optimized to no longer link to the stock registration date price.爱尔眼科董秘吴士君向证监会主席吴清建议优化股权激励限制性股票个税计税方式，不再与股票登记日市价挂钩。
2024-04-26Aier Eye Hospital announced its 2023 annual general meeting will be held on May 21, 2024, to review 10 proposals including the annual report and bank credit application.爱尔眼科公告将于2024年5月21日召开年度股东大会，审议包括年报和银行授信申请在内的10项议案。
2024-08-29Aier Eye Hospital announced a 'Quality Return Dual Enhancement' action plan, focusing on core business, digital ophthalmology, sustainability, and shareholder returns.爱尔眼科发布‘质量回报双提升’行动方案，聚焦核心业务、数字眼科、可持续发展和股东回报。
2024-10-25Aier Eye Hospital announced the 6th 'National Aier Eye Hospital Investor Open Day' to be held on October 30, 2024, with all prefecture-level and above 'Aier' brand hospitals open to investors.爱尔眼科宣布将于2024年10月30日举办第六届“全国爱尔眼科医院投资者接待日”，境内所有地级市及以上“爱尔”品牌医院向投资者开放。
2024-10-30Aier Eye Hospital launched the 'Aier Eye Hospital Shareholder Exclusive Benefits' program on its 15th listing anniversary, offering exclusive customer service, expert appointments, and discounts to investors, initially covering 33 regional hospitals.爱尔眼科在上市15周年之际推出“爱尔眼科股东专属礼遇”，为投资者提供专属客服、专家挂号、优惠等福利，首批选定33家区域中心医院。
2025-02-13Aier Eye Hospital confirmed it will release its 2024 annual report on April 25, 2025.爱尔眼科确认将于2025年4月25日披露2024年年度报告。
2025-05-20The 2024 annual general meeting approved all 10 proposals, including the profit distribution plan with 99.93% approval (99.24% from minority shareholders), and authorized bank credit applications for 2025.2024年年度股东大会审议通过全部10项议案，其中利润分配预案合并同意率99.93%（中小投资者同意率99.24%），并批准2025年银行授信申请。
2025-07-28Goldman Sachs upgraded Aier Eye Hospital to 'Buy' with a target price of 15 yuan per share.高盛集团将爱尔眼科评级上调至“买进”，目标价15元人民币。
2025-10-16Aier Eye Hospital Group announced the 7th 'National Aier Eye Hospital Investor Open Day' will be held on October 30, 2025, with the theme 'Wisdom Leads New Journey', showcasing AI, new technologies, and new services.爱尔眼科医院集团宣布将于2025年10月30日举办第七届“全国爱尔眼科医院投资者接待日”活动，主题为“智领新程”，展示人工智能、新技术、新服务。
2025-10-30Aier Eye Hospital Group held the 7th 'National Hospital Investor Open Day' with the theme 'Wisdom Leads New Journey', showcasing the 'Yuyue Adult Optical Center' and AI-powered ophthalmology applications.爱尔眼科医院集团举办第七届“全国医院投资者接待日”，主题为“智领新程”，展示了“愉阅成人配镜中心”及AI眼科应用。
2025-11-27Aier Eye Hospital held its 3rd extraordinary general meeting of 2025, electing the 7th Board of Directors: Chen Bang as Chairman, Li Li as Vice Chairman, Wu Shijun as director, and Zhou Jianjun as employee representative director. The interim dividend plan was approved with 99.8463% support.爱尔眼科召开2025年第三次临时股东大会，选举产生第七届董事会：陈邦任董事长、李力任副董事长、吴士君为董事、周建军为职工代表董事；中期分红预案以99.8463%高票通过。
2026-02-26Aier Eye Hospital stated that it does not need to issue a performance forecast per the Shenzhen Stock Exchange GEM Listing Rules (2024 Revision); 2025 operations are normal, and the annual report will be disclosed on April 24, 2026.爱尔眼科表示，根据《深圳证券交易所创业板股票上市规则（2024年修订）》无需发布业绩预告；2025年度经营正常，将于2026年4月24日披露年度报告。
2026-04-08Aier Eye Hospital completed a block trade of shares at 9.66 yuan per share, a 0.62% discount to the market close.爱尔眼科完成一笔大宗交易，成交价每股9.66元，较收盘价折价0.62%。
University & school-enterprise cooperation高校与校企合作
3 · 2024-03-02 → 2026-01-08
▾
Aier signed strategic agreements with multiple universities for talent training, discipline construction, and joint colleges.爱尔与多所高校签署战略协议，开展人才培养、学科建设和联合学院建设。
2024-03-02Aier Eye Hospital Group's Vice President and CEO of Hubei-Henan region Han Zhong visited Henan University Medical School to discuss deepening school-enterprise cooperation in talent training and discipline construction, aligning with Aier's '1+8+N' strategic plan.爱尔眼科集团董事副总裁、鄂豫大区CEO韩忠访问河南大学医学院，讨论深化校企合作，涉及人才培养和学科建设，契合爱尔‘1+8+N’战略规划。
2024-06-03Aier Eye Hospital signed a strategic cooperation agreement with North Sichuan Medical College to jointly establish the 'North Sichuan Medical College Aier Eye Optometry College'.爱尔眼科与川北医学院签署战略合作协议，共建‘川北医学院爱尔眼视光学院’。
2026-01-08Aier Eye Hospital signed a strategic cooperation agreement with Guangdong Lingnan Vocational and Technical College to jointly build a modern industrial college, a directly affiliated ophthalmic hospital, and an 'Optometry Technology Innovation and Entrepreneurship Base'.爱尔眼科与广东岭南职业技术学院签署战略合作，共建现代产业学院、直属附属眼科医院及“眼视光技术专业创新创业基地”。
Beijing Aier Yingzhi relocation & expansion北京爱尔英智搬迁扩建
6 · 2024-03-11 → 2026-06-25
▾
Aier reallocated funds and leased property for the relocation and expansion of Beijing Aier Yingzhi Eye Hospital.爱尔重新分配资金并租赁物业，用于北京爱尔英智眼科医院的搬迁扩建。
2024-03-11Aier Eye Hospital announced changing the use of ~197 million yuan of unspent raised funds from 'Nanning Aier relocation expansion' and 'IT infrastructure upgrade' projects to 'Beijing Aier Yingzhi Eye Hospital relocation expansion project'.爱尔眼科公告变更约1.97亿元募集资金用途，从‘南宁爱尔迁址扩建’和‘信息化基础设施改造’项目转至‘北京爱尔英智眼科医院迁址扩建项目’。
2024-03-12Aier Eye Hospital leased 30,530.52 sqm of property at 15 East Third Ring South Road, Chaoyang, Beijing from related party Beijing Liangshi Hospital Management Development Co. for Beijing Aier Yingzhi's new hospital, with annual rent of 35 million yuan.爱尔眼科向关联方北京亮视医院管理发展有限公司租赁北京朝阳区东三环南路15号30530.52平方米房产，用于北京爱尔英智新院，年租金3500万元。
2024-09-03Beijing Aier Yingzhi Eye Hospital, a wholly-owned subsidiary of Aier, increased registered capital from 10 million yuan to 200 million yuan.爱尔眼科全资子公司北京爱尔英智眼科医院注册资本从1000万元增至2亿元。
2024-09-11Aier signed a tripartite fund supervision agreement with Bank of Changsha and Huatai United Securities for the Beijing Aier Yingzhi relocation and expansion project; any expenditure over 39 million yuan must be reported to the sponsor.爱尔眼科与长沙银行、华泰联合证券签署募集资金三方监管协议，用于北京爱尔英智迁址扩建项目；超3900万元支出需报备保荐机构。
2025-03-24Aier Eye Hospital provided a performance bond of up to 6 million yuan to Beijing Gangyuan Architectural Decoration Engineering Co., Ltd. for its subsidiary Beijing Aier Yingzhi Eye Hospital's construction payment obligations.爱尔眼科为全资子公司北京爱尔英智眼科医院向北京港源建筑装饰工程有限公司开具不超过600万元的履约保函。
2026-06-25Aier Eye Hospital announced the postponement of the 'Beijing Aier Yingzhi Eye Hospital Relocation and Expansion Project' by one year, with the expected usable date moved from June 2026 to June 2027.爱尔眼科公告，“北京爱尔英智眼科医院迁址扩建项目”达到预计可使用状态时间由2026年6月延期至2027年6月。
Atropine eye drops & myopia control products阿托品滴眼液与近视防控产品
6 · 2024-03-14 → 2024-11-21
▾
Aier obtained approval for 0.05% atropine eye drops and partnered with Xingqi Eye Pharma for 0.01% atropine, expanding myopia control offerings.爱尔获批0.05%阿托品滴眼液，并与兴齐眼药合作引入0.01%阿托品，扩展近视防控产品线。
2024-03-14Aier Eye Hospital disclosed it has obtained the 'Medical Institution Preparation License' and approval for 0.05% atropine eye drops, which have entered clinical use for myopia control in adolescents.爱尔眼科披露已取得《医疗机构制剂许可证》，0.05%阿托品滴眼液获相关批文并进入临床，用于青少年近视防控。
2024-04-10Aier Eye Hospital and Xingqi Eye Pharma signed an agreement to introduce China's first approved 0.01% atropine eye drops (Xingqi Meiuopin) for delaying myopia progression in children aged 6-12.爱尔眼科与兴齐眼药签约，引进国内首款获批的0.01%硫酸阿托品滴眼液（兴齐美欧品），用于延缓6至12岁儿童近视进展。
2024-04-25Aier Eye Hospital disclosed that its 0.05% atropine eye drops have obtained hospital preparation approval, and the company holds a Pharmaceutical Preparation License for use within its network.爱尔眼科披露其0.05%硫酸阿托品滴眼液已取得医疗机构制剂批件，并持有《医疗机构制剂许可证》，可在集团内使用。
2024-05-02Xingqi Eye Medicine (兴齐眼药) announced cooperation with Aier Eye Hospital Group to introduce low-concentration atropine (阿托品) into Aier's hospitals.兴齐眼药宣布与爱尔眼科医院集团合作，将低浓度阿托品引入爱尔旗下医院。
2024-08-16Xingqi Eye Pharma announced cooperation with Aier Eye Hospital Group and other private chains for its low-concentration atropine eye drops.兴齐眼药宣布其低浓度阿托品滴眼液已与包括爱尔眼科集团在内的国内多家民营连锁医疗机构达成合作。
2024-11-21Aier Eye Hospital confirmed in an investor interaction that its optometry business offers a comprehensive myopia prevention system including low-concentration atropine, OK lenses, and defocus glasses, and is not disrupted by new eye drops.爱尔眼科在投资者互动中确认，其视光业务提供包括低浓度阿托品、OK镜、离焦镜片在内的综合近视防控体系，不受新眼药水颠覆性冲击。
Smart wearable & AI-powered myopia prevention (Yunjia/Xiaoqingkui)智能穿戴与AI近视防控（云夹/小青葵）
4 · 2024-03-15 → 2026-01-10
▾
Aier upgraded its Yunjia smart wearable and launched Xiaoqingkui myopia prevention lenses and smart glasses for children.爱尔升级云夹智能穿戴设备，并推出小青葵近视防控镜片和儿童智能眼镜。
2024-03-15Aier Eye Hospital upgraded its self-developed smart wearable device 'Yunjia' (Cloud Clip) from version 1.0 to 3.0 for real-time monitoring of children's eye-use behavior and personalized myopia prevention.爱尔眼科自主研发的近视防控智能可穿戴设备‘云夹’从1.0版本升级至3.0版本，用于实时监测儿童用眼行为并提供个性化近视防控方案。
2024-09-23At the 19th International Myopia Conference (IMC) hosted by Aier, the company launched 'Xiaoqingkui' myopia prevention lenses and a wide-field retinal refractometer (VPR) for high-precision full-retina optical testing.在第19届世界近视眼大会上，爱尔眼科发布“小青葵”近视预防镜片和可进行高精度全视网膜光学检测的广域视网膜屈光度测量仪（VPR）。
2025-12-04Aier Eye Hospital stated that in mid-2024 it signed a strategic cooperation framework agreement with iFLYTEK to jointly explore AI+medical application scenarios. It also independently developed the world's first smart glasses for children's vision management, 'Xiaoqingkui' (Little Green Sunflower), based on biosensing, big data, and cloud sync.爱尔眼科表示，2024年中与科大讯飞签署战略合作框架协议，共同探索AI+医疗应用场景；并自主研发全球首款少儿视力管理智能眼镜“小青葵”，基于生物传感、大数据和云同步技术。
2026-01-10Aier Eye Hospital's self-developed 'Xiaoqingkui' (Little Sunflower) series products have achieved mass production, with good myopia prevention and control effects.爱尔眼科自主研发的“小青葵”系列产品已实现量产，具有良好的近视防控效果。
Equity incentive & restricted share unlock股权激励与限售股解禁
12 · 2024-03-22 → 2026-03-18
▾
Aier managed multiple equity incentive plan unlocks, repurchases, and cancellations of restricted shares.爱尔管理多次股权激励计划解禁、回购和注销限制性股票。
2024-03-22Aier Eye Hospital had 198,800 restricted shares (equity incentive) become tradable, representing 0.0% of total equity; cumulative 321 million shares (3.44%) unlocked in the past year.爱尔眼科19.88万股股权激励限售股份解禁上市，占总股本0.0%；近一年累计解禁3.21亿股，占总股本3.44%。
2024-06-10Aier Eye Hospital will have 20.6766 million restricted shares (equity incentive) unlocked on June 17, 2024, with a market value of about 244 million yuan.爱尔眼科将于2024年6月17日解禁2067.66万股股权激励限售股，市值约2.44亿元。
2024-06-14Aier Eye Hospital's board of directors reviewed the proposal on the third unlocking period conditions for the 2021 restricted stock incentive plan (first grant), but shares will not be listed temporarily.爱尔眼科董事会审议2021年限制性股票激励计划首次授予部分第三个解除限售期条件成就但股票暂不上市的议案。
2024-09-20Aier Eye Hospital board approved the proposal on lifting the lock-up for the third release period of the 2021 restricted stock incentive plan (deferred grant portion), but shares will not be listed temporarily.爱尔眼科董事会审议通过2021年限制性股票激励计划暂缓授予部分第三个解除限售期条件成就但股票暂不上市的议案。
2024-11-03Aier Eye Hospital announced that 6.4171 million restricted shares from the 2021 equity incentive plan will be unlocked and listed for trading on November 6, 2024, covering 1,068 grantees.爱尔眼科公告称，2021年限制性股票激励计划预留授予部分第二个解除限售期解除限售股份641.71万股将于2024年11月6日上市流通，涉及激励对象1068名。
2024-12-11Aier announced the release of 20 million restricted shares (0.2144% of total) from its 2021 stock incentive plan on Dec 16, 2024, for 4,582 eligible employees.爱尔眼科公告2021年限制性股票激励计划首次授予部分第三个解除限售期2000万股（占总股本0.2144%）于2024年12月16日上市流通，涉及4582名激励对象。
2025-03-06Aier Eye Hospital announced the repurchase and cancellation of 1,617,825 restricted shares (1,265,819 initial grant shares at 11.96 yuan/share and 352,006 reserved grant shares at 11.96 yuan/share) due to unmet incentive conditions, reducing the number of incentive recipients.爱尔眼科公告回购注销1,617,825股限制性股票（首次授予1,265,819股，回购价11.96元/股；预留授予352,006股，回购价11.96元/股），因激励条件未达成，激励对象人数相应减少。
2025-05-066.5697 million restricted shares (0.07% of total share capital) from the 2021 equity incentive plan became eligible for release, but the shares will remain locked until Nov 5, 2025.2021年限制性股票激励计划中656.97万股限售股（占总股本0.07%）解除限售条件成就，但股票暂不上市，继续禁售至2025年11月5日。
2025-06-16Aier Eye Hospital announced that 4,418 incentive recipients met conditions for the fourth release of the 2021 restricted stock incentive plan, involving 19,390,095 shares (0.2079% of total), with a 6-month lock-up extension to Dec 14, 2025.爱尔眼科公告，2021年限制性股票激励计划首次授予部分第四个解除限售期条件达成，涉及4418名激励对象、1939万股（占总股本0.2079%），禁售期延长至2025年12月14日。
2025-11-03Aier Eye Hospital announced that 1,025 incentive recipients under the 2021 restricted stock incentive plan (reserved grant portion) met 100% vesting conditions for the third release period, with 6.24 million shares (0.0669% of total shares) becoming tradable on November 6, 2025.爱尔眼科公告，2021年限制性股票激励计划预留授予部分第三个解除限售期，1025名激励对象均满足100%解除限售条件，可解除限售624万股（占总股本0.0669%），上市流通日为2025年11月6日。
2025-12-10Aier Eye Hospital announced that 19,390,095 restricted shares (0.2079% of total shares) from the 2021 stock incentive plan's fourth tranche will be unlocked and listed for trading on December 15, 2025, covering 4,418 eligible grantees.爱尔眼科公告，2021年限制性股票激励计划首次授予部分第四个解除限售期的19,390,095股（占总股本0.2079%）将于2025年12月15日上市流通，涉及4,418名激励对象。
2026-03-18Aier Eye Hospital announced the release of 198,798 restricted shares from the 2021 incentive plan for 3 executives, effective March 23, 2026.爱尔眼科公告2021年限制性股票激励计划暂缓授予部分第四个解除限售期198,798股于2026年3月23日上市流通。
New clinic & hospital openings (domestic network)国内新诊所与医院开业
11 · 2024-03-30 → 2026-05-22
▾
Aier opened multiple new clinics and hospitals across China, expanding its domestic network.爱尔在全国多地开设新诊所和医院，扩展国内网络。
2024-03-30Aier Eye Hospital opened its 19th chain clinic in Fujian province, Quanzhou Taiwan Investment Zone Aier Eye Clinic, covering nearly 600 sqm, offering comprehensive eye care and myopia prevention services.爱尔眼科福建省区第19家连锁机构——泉州台商投资区爱尔眼科门诊开业，面积近600平米，提供综合眼健康和近视防控服务。
2024-05-20Aier Eye Hospital CEO Li Li stated that Guiyang Aier is expected to open normally by the end of 2024.爱尔眼科总经理李力表示贵阳爱尔预计2024年底正常开业。
2024-07-13Beijing Aier Eye Hospital officially launched, initiating cataract disability assistance public welfare project, national children's eye care painting competition Beijing station, and whole-life-cycle eye health management public service project.北京爱尔眼科医院启航，启动了“白内障助残公益项目”、“爱尔眼科杯”全国少年儿童爱眼护眼绘画作品征集北京站活动及“全生命周期眼健康管理公益服务项目”。
2024-08-03Kunming Aier Eye Hospital opened a new clinic at Xiaokang Avenue, establishing a 'one hospital, two clinics' model in Kunming.昆明爱尔眼科医院小康大道诊所正式开诊，在昆明构建‘一院两诊所’模式。
2024-09-14Fuzhou Changle Aier Eye Clinic opened, the 21st chain in Fujian province, offering pediatric myopia prevention, strabismus, dry eye, and adult glasses clinics.福州长乐爱尔眼科门诊部开业，为福建省区第21家连锁机构，开设青少年近视防控、斜视、干眼、成人配镜门诊。
2024-09-22Chongqing Shapingba Aier Eye Hospital officially opened, with a 'Chongqing Eye Health Science Base (Shapingba Branch)' plaque awarded.重庆沙坪坝爱尔眼科医院正式开诊，获授“重庆市眼健康科普基地（沙坪坝分基地）”铜牌。
2025-02-07Hanzhong Aier Eye Hospital South Branch Eye Clinic officially opened, marking a new milestone for ophthalmic services in Nanzheng District.汉中爱尔眼科南院眼科诊所正式开诊，标志着南郑地区眼科医疗服务迈入新里程碑。
2025-03-09Kaifeng Aier Eye Hospital, the sixth Aier hospital in Henan province, officially opened, adopting a 'provincial experts, local pricing, chain service' model to provide convenient ophthalmic services.开封爱尔眼科医院正式启航，为爱尔眼科在河南建立的第六家医院，采用“省会专家、本地收费、连锁服务”模式。
2025-03-30Tianjin University Aier Eye Hospital started construction of its new site in Nankai District, with a total floor area of over 36,000 sqm, integrating Tianjin University's research and teaching resources with Aier's clinical expertise.天津大学爱尔眼科医院新址在南开区开工建设，总建筑面积超36,000平方米，融合天津大学科研教学资源与爱尔眼科临床技术。
2025-10-29Shaoguan Aier Eye Hospital held a topping-out ceremony for its new hospital project, which started construction in June 2025 and took only 4 months to reach this milestone.韶关爱尔眼科医院新院项目举行封顶仪式，该项目于2025年6月正式开工建设，仅用4个月实现封顶。
2026-05-22The main structure of Tianjin University Aier Eye Hospital project was topped out. The project has a total floor area of 36,800 square meters and is a key livelihood project for regional medical capacity improvement.天津大学爱尔眼科医院项目主体结构封顶，总建筑面积3.68万平方米，是区域医疗能力提升重点民生工程。
Academic forums & international conferences学术论坛与国际会议
11 · 2024-04-03 → 2025-11-28
▾
Aier hosted and participated in major ophthalmology conferences including WAEH, IMC, and WCPOS, showcasing research.爱尔主办并参与WAEH、IMC、WCPOS等重大眼科会议，展示研究成果。
2024-04-03Aier Eye Hospital Group hosted the 2nd International Forum on Corneal and Ocular Surface Diseases in Changsha, focusing on eye bank standardization, dry eye diagnosis advances, and corneal transplantation challenges.爱尔眼科医院集团在长沙主办第二届角膜及眼表疾病国际论坛，聚焦眼库标准化建设、干眼诊疗新进展及角膜移植挑战。
2024-05-17Aier Eye Hospital held the 'Global Customization of Refractive Surgery' forum, established the 'Aier Global Refractive Surgery Expert Committee', and released the 'Aier International Refractive Specialist Training Program' and 'China-Europe International Myopia Surgery Big Data White Paper 2.0'.爱尔眼科举办“近视手术全球定制”论坛，成立“爱尔全球屈光手术专家委员会”，发布“爱尔国际屈光专科培训项目”和《中、欧国际近视手术大数据白皮书2.0》。
2024-07-31Aier Eye Hospital's experts participated in the 2024 World Congress of Pediatric Ophthalmology and Strabismus (WCPOS) in Kuala Lumpur, Malaysia, presenting research on children's cataracts, retinopathy of prematurity, and pediatric glaucoma.爱尔眼科专家团队参加在马来西亚吉隆坡举办的2024年世界小儿眼科与斜视学大会，围绕儿童白内障、早产儿视网膜病变等议题进行学术报告。
2024-08-21Fuzhou Aier Eye Hospital held a countdown event for the 19th International Myopia Conference (IMC) to be held in China from September 23-28, 2024, which Aier won the right to host.福州爱尔眼科医院举行第19届世界近视眼大会（IMC）开幕倒计时35天仪式，该大会将于2024年9月23日至28日在中国举办，爱尔眼科获得主办权。
2024-11-11Aier Eye Hospital co-hosted the 18th World Association of Eye Hospitals (WAEH) Annual Meeting in China, with over 200 delegates from 20 countries; Aier is the only Chinese board member of WAEH.爱尔眼科在中国共同主办了第18届世界眼科医院协会（WAEH）年会，来自20个国家的200余位代表参会；爱尔眼科是WAEH董事会中唯一的中国成员。
2024-12-02Aier's Southeast Asia ISEC Group held the first ISEC Glaucoma Symposium in Kuala Lumpur, Malaysia, with 200 ophthalmologists from 5 countries.爱尔眼科东南亚ISEC集团在马来西亚吉隆坡举办首届青光眼国际论坛，来自5个国家的200名眼科医生参与。
2025-05-08Aier Eye Hospital Group Fujian delegation presented research on diabetic keratopathy at ARVO 2025 (Salt Lake City, USA), revealing the role of oxidative stress and ferroptosis.爱尔眼科福建省区专家代表团在ARVO 2025（美国盐湖城）展示糖尿病性角膜病变研究成果，揭示氧化应激和铁死亡的作用机制。
2025-07-21Aier Eye Hospital's glaucoma team presented three research results at the 11th World Glaucoma Congress (WGC 2025) in Hawaii, including a ferroptosis mechanism treatment strategy (digoxin eye drops) for glaucoma.爱尔眼科青光眼团队在第11届世界青光眼大会（WGC 2025）上展示三项研究成果，包括针对青光眼的铁死亡机制治疗策略（地高辛滴眼液）。
2025-09-04Aier Eye Hospital held the 2025 Refractive Cataract Surgery International Forum (IRCS) and the first International Summit on Presbyopia Correction MDT Management in Hangzhou; established the industry's first 'Presbyopia Management MDT Group', opened 'Presbyopia Correction Clinics' in 30 cities nationwide, and released the industry's first 'Digital Navigation Cataract Surgery Expert Consensus'.爱尔眼科在杭州举办2025年屈光性白内障手术国际论坛（IRCS）暨第一届老视矫正MDT管理国际高峰论坛；成立业内首个“老视管理MDT学组”、开设全国30城“老视矫正门诊”、发布行业首份《数字化导航白内障手术专家共识》。
2025-10-31Aier Eye Hospital Group's Cornea and Ocular Surface Academic Group hosted a 'Dry Eye Practical Operation and Standardized Diagnosis and Treatment' symposium, demonstrating standardized SOP processes and contributing to the national dry eye diagnosis and treatment expert consensus.爱尔眼科医院集团角膜及眼表学组承办“干眼实操与规范化诊疗”专题会议，展示标准化操作流程，并参与编写我国干眼诊治专家共识。
2025-11-28Aier Eye Hospital co-hosted the International Retina Summit (IRS100·2025) in Changsha, Hunan, with over 300 domestic and international experts, covering gene therapy, AI, surgical robots, and stem cell research.爱尔眼科联合主办国际视网膜高峰论坛百人会(IRS100)·2025在长沙举办，汇聚300余位海内外专家，涵盖基因治疗、人工智能、手术机器人、干细胞研究等前沿方向。
Strategic cooperation & partnerships战略合作与伙伴关系
9 · 2024-04-15 → 2026-04-24
▾
Signing of strategic cooperation agreements with various partners including lens companies, tech firms, and medical platforms.与镜片公司、科技公司及医疗平台等签署战略合作协议。
2024-04-15Tianjin University Aier Eye Hospital signed a medical alliance agreement with Nandingdi Hospital to share resources in management, discipline building, and clinical applications, improving grassroots eye care.天津大学爱尔眼科医院与南开区王顶堤医院签署医联体合作协议，在管理、学科建设和临床应用方面共享资源，提升基层眼科诊疗水平。
2024-09-12Aier Eye Research Institute signed a strategic cooperation agreement with Zhongke Zhiying to jointly build an ophthalmic magnetoencephalography medical platform, including the first international pediatric neuro-ophthalmic MEG system.爱尔眼视光研究所与中科知影签署战略合作协议，共建眼科脑磁图医疗平台，包括国际首个儿童神经性眼病脑磁图系统。
2024-10-09Aier Eye Hospital Group signed a strategic cooperation agreement with Foshan Southern Eye Valley Industrial Park and Foshan Nanhai Big Health Industry Promotion Center to jointly develop the eye health industry cluster.爱尔眼科医院集团与佛山市南方眼谷产业园、佛山市南海大健康产业促进中心签署战略合作协议，共同打造眼健康产业集群。
2025-01-15Aier Eye Hospital and Meituan Pharmaceutical Health signed a strategic cooperation agreement to jointly establish the China 'Excellent Vision' Plan, aiming to serve 100 million people, focusing on youth optometry, adult refractive surgery, and elderly eye diseases, and accelerating the digitalization of all Aier institutions online.爱尔眼科与美团医药健康签署战略合作协议，共同成立中国“优”视力计划，旨在为1亿人护航眼健康，重点关注青少年视光、成人屈光、老年人眼部疾病，并加快推进爱尔眼科全量机构线上化。
2025-05-24Aier Eye Hospital and Meituan Pharmaceutical Health launched the 'China Excellent Vision Plan', aiming to build a lifelong eye health management system for 100 million people within three years, focusing on youth myopia, adult refractive, and elderly eye diseases.爱尔眼科与美团医药健康发起中国“优”视力计划，目标三年内为1亿人构建全生命周期眼健康管理体系，重点关注青少年视光、成人屈光、老年人眼病。
2025-08-05Signed a strategic cooperation agreement with Mingyue Lens Co., Ltd. covering product procurement, clinical research, brand, talent training, and public welfare.与明月镜片股份有限公司签署战略合作协议，涵盖产品采购、临床科研、品牌、人才培养和公益等领域。
2025-09-06Aier Eye Hospital and Johnson & Johnson Vision (强生眼力健) announced a cooperation to jointly develop and promote a high-standard, comprehensive precision refractive cataract diagnosis and treatment solution, aiming to establish a replicable 'standardized model' for precision refractive cataract diagnosis and treatment.爱尔眼科与强生眼力健宣布合作，共同打造并推广一套高标准、全方位的精准屈光白内障诊疗解决方案，旨在建立可推广的屈光性白内障精准诊疗“标准化范本”。
2026-01-28Aier Eye Hospital and Meituan Medical Health upgraded cooperation: over 100 Aier hospitals launched online appointment registration services on the Meituan platform, covering Beijing, Chengdu, Guangzhou, Shenzhen, Changsha, Chongqing, etc.爱尔眼科与美团医药健康合作全面升级：全国超百家爱尔眼科医院在美团上线挂号服务，覆盖北京、成都、广州、深圳、长沙、重庆等地。
2026-04-24Aier Eye Hospital hosted a delegation from the China-US Youth Health Dialogue, focusing on eye health cooperation.爱尔眼科接待中美青年卫生健康对话活动代表团，聚焦眼健康合作。
Other developments其他动态
9 · 2024-04-17 → 2026-03-30
▾
Assorted one-off developments.零散的一次性动态。
2024-04-17Former Beijing Tongren Hospital retinal specialist Liu Ningpu joined Aier Eye Hospital as Vice President of Sichuan Province and Chief Expert for fundus diseases, and the hospital launched an intravitreal injection center.原北京同仁医院眼底病专家刘宁朴教授加盟爱尔眼科，出任四川省区副总院长及眼底病首席专家，同时四川眼科医院成立眼内注药中心。
2024-06-06Aier Eye Hospital launched a pediatric eye disease expert tour and frontier technology seminar in Chongqing, aiming to improve pediatric ophthalmology diagnosis and treatment.爱尔眼科在重庆启动小儿眼病专家巡诊暨前沿技术研讨会，提升小儿眼病诊疗水平。
2024-06-15Aier Eye Hospital held the Fundus Disease Forum 2024 (Chongqing) and established the 'Wang Yi Remote Fundus Reading Studio' to empower grassroots hospitals.爱尔眼科举办眼底病论坛2024（重庆站），成立‘王一眼底远程阅片工作室’赋能基层医院。
2024-11-28Aier Eye Hospital's Lijiang branch invited Professor Zhou Qizhi, a domestic refractive surgery expert, to conduct consultations and perform corneal laser and ICL surgeries for local patients.丽江爱尔眼科医院邀请国内屈光手术专家周奇志教授到院会诊，为当地患者进行角膜激光手术和ICL晶体植入手术。
2025-03-06Aier Eye Hospital renewed two property lease contracts as related-party transactions: Wuhan Aier Hankou Hospital leased 18,409.42 sqm for 7.74 million yuan/year (2025-2027), and Hunan Kangshijia Pharmaceutical leased 4,508.86 sqm for office use.爱尔眼科续签两项关联租赁合同：武汉爱尔汉口医院租赁18,409.42平方米，年租金774万元（2025-2027年）；湖南康视佳医药租赁4,508.86平方米办公用房。
2025-03-11Aier Eye Hospital released the 'Expert Consensus on Green Channel for Emergency Referral of Glaucoma' across ten major regions nationwide during World Glaucoma Week.爱尔眼科在全国十大区域同步发布《爱尔眼科青光眼急重症转诊绿色通道专家共识》。
2025-09-09Aier Eye Hospital's Vice President Wang Lihua shared the group's talent cultivation achievements and the 'soil-seed-forest' talent ecosystem; the group has established a scientific research transformation platform including a national postdoctoral research workstation and cooperates with 16 universities including Central South University and Wuhan University for full-sequence training from bachelor's to doctoral levels.爱尔眼科副总裁王丽华分享集团人才培养成果与“土壤-种子-森林”人才生态体系；集团搭建涵盖国家博士后科研工作站的科研转化平台，并与中南大学、武汉大学等16所高校合作构建本科至硕博的全序列培养链。
2025-09-10Aier Eye Hospital's Cataract Academic Group Youth Committee was officially established, providing a platform for academic exchange and capability improvement for young experts, injecting fresh vitality into the inheritance and development of the cataract discipline.爱尔眼科医院集团白内障学组青年委员会正式宣布成立，为青年专家提供学术交流、能力提升的优质平台，为白内障学科的传承与发展注入活力。
2026-03-30Aier Eye Hospital released a women's eye care guide recommending low-add progressive lenses ('phone glasses') for multi-scenario use, targeting office workers and mothers.爱尔眼科发布女性护眼指南，推荐低下加度渐进镜（“手机镜”），针对职场白领和宝妈等多场景用眼需求。
Financial results & operational metrics财务业绩与运营指标
20 · 2024-04-25 → 2026-05-12
▾
Aier reported quarterly and annual financial results, including revenue, net profit, outpatient visits, and surgery volumes.爱尔公布季度和年度财务业绩，包括收入、净利润、门诊量和手术量。
2024-04-25Aier Eye Hospital reported Q1 2024 results: revenue 5.196 billion yuan (+3.5% YoY), net profit 899 million yuan (+15.16% YoY).爱尔眼科发布2024年一季度业绩：营业收入51.96亿元（同比+3.5%），归母净利润8.99亿元（同比+15.16%）。
2024-04-25Aier Eye Hospital announced 2023 annual results: revenue 20.367 billion yuan (+26.43% YoY), net profit 3.359 billion yuan (+33.07% YoY); proposed cash dividend of 1.50 yuan per 10 shares, totaling 1.395 billion yuan.爱尔眼科发布2023年年报：营业收入203.67亿元（同比+26.43%），归母净利润33.59亿元（同比+33.07%）；拟每10股派发现金红利1.50元，合计13.95亿元。
2024-04-25Aier Eye Hospital reported 2023 operational metrics: outpatient visits reached 15.1064 million (+34.26% YoY), surgeries 1.1837 million cases (+35.95% YoY).爱尔眼科2023年运营数据：门诊量1510.64万人次（同比+34.26%），手术量118.37万例（同比+35.95%）。
2024-08-23Aier Eye Hospital reported H1 2024 results: revenue 10.545 billion yuan (+2.86% YoY), net profit 2.05 billion yuan (+19.71% YoY), outpatient visits 7.9407 million (+9.23%), surgeries 649,900 (+6.92%).爱尔眼科发布2024年半年报：营业收入105.45亿元（同比+2.86%），净利润20.5亿元（同比+19.71%），门诊量794.07万人次（+9.23%），手术量64.99万例（+6.92%）。
2024-10-30Aier Eye Hospital reported Q3 2024 results: 9M revenue 16.302 billion yuan (+1.58% YoY), net profit 3.452 billion yuan (+8.5% YoY); Q3 revenue 5.756 billion yuan (-0.68% YoY), net profit 1.402 billion yuan (-4.56% YoY).爱尔眼科发布2024年三季报：前三季度营收163.02亿元（同比+1.58%），净利润34.52亿元（同比+8.5%）；第三季度营收57.56亿元（同比-0.68%），净利润14.02亿元（同比-4.56%）。
2024-11-01Aier Eye Hospital reported Q3 2024 results: revenue RMB 5.756 billion, -0.68% YoY; net profit attributable to parent RMB 1.402 billion, -4.56% YoY. 9M 2024 revenue RMB 16.302 billion, +1.58% YoY; net profit RMB 3.452 billion, +8.5% YoY.爱尔眼科公布2024年第三季度业绩：营收57.56亿元，同比下降0.68%；归母净利润14.02亿元，同比下降4.56%。2024年前三季度营收163.02亿元，同比增长1.58%；归母净利润34.52亿元，同比增长8.5%。
2025-04-24Aier Eye Hospital reported Q1 2025 revenue of RMB 6.026 billion, +15.97% YoY; net profit of RMB 1.049 billion, +16.71% YoY.爱尔眼科公布2025年第一季度营业收入60.26亿元，同比增长15.97%；净利润10.49亿元，同比增长16.71%。
2025-04-24Aier Eye Hospital released 2024 annual report: revenue RMB 20.98 billion, +3.0% YoY; net profit RMB 3.56 billion, +5.9% YoY; proposed dividend of RMB 1.6 per 10 shares, totaling RMB 1.487 billion.爱尔眼科发布2024年年报：营业收入209.8亿元，同比增长3.0%；净利润35.6亿元，同比增长5.9%；拟10派1.6元，合计派发现金红利14.87亿元。
2025-04-29Aier Eye Hospital reported that 2024 refractive surgery revenue grew only 2.31% YoY, with gross margin declining to 55.11%; non-GAAP net profit fell 11.82% YoY, the first decline since listing.爱尔眼科2024年屈光项目营收同比仅增长2.31%，毛利率下滑至55.11%；扣非净利润同比下降11.82%，为上市以来首次下滑。
2025-05-06Q1 2025 results: revenue 6.026 billion yuan (+15.97% YoY), net profit 1.05 billion yuan (+16.71% YoY), gross margin 48.02%.2025年一季度业绩：营业收入60.26亿元（同比+15.97%），归母净利润10.5亿元（同比+16.71%），毛利率48.02%。
2025-05-072024 annual results: revenue 20.983 billion yuan (+3.02% YoY), net profit 3.556 billion yuan (+5.87% YoY), but core net profit (excl. non-recurring) fell 11.82% to 3.099 billion yuan, the first decline since listing.2024年年报：营业收入209.83亿元（同比+3.02%），归母净利润35.56亿元（同比+5.87%），但扣非归母净利润30.99亿元（同比-11.82%），上市以来首次负增长。
2025-08-26Released 2025 semi-annual report: revenue 11.507 billion yuan (+9.12% YoY), net profit 2.051 billion yuan (+0.05% YoY), non-GAAP net profit 2.040 billion yuan (+14.30% YoY).发布2025年半年度报告：营业收入115.07亿元（同比+9.12%），净利润20.51亿元（同比+0.05%），扣非净利润20.40亿元（同比+14.30%）。
2025-09-03Aier Eye Hospital released 2025 semi-annual report: revenue 11.507 billion yuan, +9.12% YoY; net profit attributable to parent 2.051 billion yuan, +0.05% YoY; non-GAAP net profit +14.3% YoY. No cash dividend, no bonus shares, no capital reserve capitalization.爱尔眼科发布2025年半年度报告：营业收入115.07亿元，同比增长9.12%；归母净利润20.51亿元，同比增长0.05%；扣非净利润同比增长14.3%。不进行现金分红、不送红股、不以公积金转增股本。
2025-10-27Aier Eye Hospital Group reported Q3 2025 revenue of 5.977 billion yuan (+3.83% YoY) and net profit of 1.064 billion yuan (-24.12% YoY); first three quarters revenue of 17.484 billion yuan (+7.25% YoY) and net profit of 3.115 billion yuan (-9.76% YoY).爱尔眼科医院集团发布2025年第三季度报告：三季度营收59.77亿元（同比+3.83%），净利润10.64亿元（同比-24.12%）；前三季度营收174.84亿元（同比+7.25%），净利润31.15亿元（同比-9.76%）。
2025-11-03Aier Eye Hospital reported Q3 2025 revenue of 5.977 billion yuan, up 3.83% YoY; net profit attributable to shareholders was 1.064 billion yuan, down 24.12% YoY. For the first three quarters, cumulative revenue was 17.484 billion yuan, up 7.25% YoY; net profit was 3.115 billion yuan, down 9.76% YoY.爱尔眼科公布2025年第三季度营收59.77亿元，同比增长3.83%；归母净利润10.64亿元，同比下降24.12%。前三季度累计营收174.84亿元，同比增加7.25%；净利润31.15亿元，同比下降9.76%。
2025-11-12Aier Eye Hospital explained that the decline in net profit was mainly due to depreciation, labor, and consumable costs from newly completed large hospitals, plus exchange losses, financial expenses, and investment income fluctuations.爱尔眼科解释增收不增利主要系多家大型医院建成运营带来折旧摊销、人力薪资、耗材药品等成本费用提高，以及汇兑损益、财务费用、投资收益和公允价值变动产生阶段性影响。
2026-04-23Aier Eye Hospital reported Q1 2026 revenue of 6.396 billion yuan, up 6.15% YoY; net profit of 1.181 billion yuan, up 12.46% YoY.爱尔眼科2026年一季度营收63.96亿元，同比增长6.15%；净利润11.81亿元，同比增长12.46%。
2026-04-23Aier Eye Hospital reported FY2025 impairment provisions of 302 million yuan, including 156 million yuan in goodwill impairment for over 20 subsidiaries.爱尔眼科2025年计提资产减值准备3.02亿元，其中商誉减值1.56亿元，涉及20余家子公司。
2026-05-08Aier Eye Hospital released its 2025 Sustainability Report, reporting 2025 annual outpatient visits exceeded 18.89 million (up 11.52% YoY) and surgeries reached 1.68 million (up 5.77% YoY).爱尔眼科发布《2025年度可持续发展报告》，2025年门诊量超1889万人次（同比+11.52%），手术量168万例（同比+5.77%）。
2026-05-12Aier Eye Hospital released its 2025 annual report and 2026 Q1 report: 2025 revenue was 22.353 billion yuan (up 6.53% YoY), net profit attributable to parent was 3.24 billion yuan (down 8.88% YoY); 2026 Q1 revenue was 6.396 billion yuan (up 6.15% YoY), net profit was 1.18 billion yuan (up 12.46% YoY).爱尔眼科披露2025年年报和2026年一季报：2025年营收223.53亿元（同比+6.53%），归母净利润32.4亿元（同比-8.88%）；2026年Q1营收63.96亿元（同比+6.15%），净利润11.8亿元（同比+12.46%）。
AI, digital health & R&D人工智能、数字健康与研发
8 · 2024-05-07 → 2025-05-11
▾
Development of AI models, digital humans, software copyrights, and R&D project recognitions.AI模型、数字人、软件著作权开发及研发项目认定。
2024-05-07Aier Eye Hospital disclosed AI-assisted diagnosis cooperation with the Institute of Computing Technology, Chinese Academy of Sciences, building an ophthalmic image processing platform and fundus AI auxiliary diagnosis model.爱尔眼科披露与中国科学院计算技术研究所合作搭建眼科影像处理平台和眼底AI辅诊模型。
2024-10-28Aier Eye Hospital released the digital human 'Eyecho' (Ai Ke) at the opening ceremony of the Northeast University Liaoning Aier Eye Hospital Regional Ophthalmology Medical Center, including multiple versions for patient education, lobby display, and post-operative service.爱尔眼科在东北大学附属辽宁爱尔眼科医院区域眼科医学中心开诊仪式上发布数字人“爱科（Eyecho）”，包括患教、展示和术后服务等多款版本。
2025-01-16Aier Eye Hospital released the digital human 'Eyecho', which integrates generative AI and computer graphics, equipped with the self-developed ophthalmology large model AierGPT, to assist in intelligent ophthalmology services.爱尔眼科发布数字人“爱科（Eyecho）”，集合生成式人工智能和计算机图形学技术，搭载自主研发的眼科大模型AierGPT，助力眼科服务智能化。
2025-01-21Aier Eye Hospital newly registered two software copyrights: 'Aier Eye Eyelid Tumor Intelligent Screening Mini Program 1.0' and 'Aier Eye Lacrimal Disease AI-Assisted Diagnosis System 1.0'.爱尔眼科新注册2项软件著作权：《爱尔眼科眼睑肿物智能筛查小程序1.0》和《爱尔眼科泪器病AI辅助诊断系统1.0》。
2025-03-25Aier Eye Hospital disclosed in investor relations activities that it has launched the AierGPT ophthalmic vertical large model and digital human 'Eyecho', and plans to introduce new procedures such as Full-Femtosecond Pro and ICL V5 crystal in 2025.爱尔眼科在投资者关系活动中披露，已推出AierGPT眼科垂直大模型和数字人“爱科”，并计划2025年推出全飞秒Pro及ICL V5晶体等新术式。
2025-04-09Aier Eye Hospital newly registered two software copyrights: 'Aier Remote Image Reading System 1.0' and 'Aier Remote Medical Platform System 1.0'.爱尔眼科新注册了2个项目的软件著作权，包括《爱尔远程阅片系统1.0》、《爱尔远程医疗平台系统1.0》。
2025-04-25Aier Eye Hospital's 'High-realism Personalized Ophthalmology Digital Human Base Development and Application' project was selected as a Hunan Province 'Digital New Infrastructure' landmark project.爱尔眼科“高真实感个性化眼科数字人底座开发与应用”入选湖南省“数字新基建”标志性项目。
2025-05-11Registered new software copyright 'Aier Medical Cloud Platform 1.0'; total 9 new software copyrights in 2025. R&D spending in 2024 was 321 million yuan, down 3.86% YoY.新注册《爱尔医疗云平台1.0》软件著作权；2025年以来共注册9个软件著作权。2024年研发投入3.21亿元，同比减少3.86%。
AI ophthalmology & iFlytek partnershipAI眼科与科大讯飞合作
21 · 2024-05-21 → 2026-06-05
▾
Aier partnered with iFlytek to develop AI+ophthalmology using the Spark large model, and launched AierGPT and digital human Eyecho.爱尔与科大讯飞合作开发AI+眼科，使用星火大模型，并推出爱尔GPT和数字人爱可。
2024-05-21Aier Eye Hospital Chairman Chen Bang visited iFlytek (科大讯飞) headquarters and reached consensus on strategic cooperation in AI ophthalmology, including using iFlytek Spark large model for intelligent diagnosis, treatment, and rehabilitation.爱尔眼科董事长陈邦走访科大讯飞总部，就人工智能在眼科领域的战略合作达成共识，包括利用讯飞星火大模型探索智能诊断、治疗和康复。
2024-06-15Aier Eye Hospital signed a strategic cooperation framework agreement with iFlytek to jointly build 'AI + Ophthalmology', leveraging iFlytek's Spark medical large model.爱尔眼科与科大讯飞签订战略合作框架协议，共同打造‘AI+眼科’，利用讯飞星火医疗大模型。
2024-07-10Aier Eye Hospital signed a strategic cooperation framework agreement with iFlytek Co., Ltd. to jointly promote 'AI + Ophthalmology', establishing a joint innovation center empowered by iFlytek Spark medical large model.爱尔眼科与科大讯飞股份有限公司签订战略合作框架协议，共同推动“AI+眼科”深度融合，成立大企业联合创新中心，由讯飞星火医疗大模型赋能。
2024-12-12Aier Eye Hospital was added to the 'Artificial Intelligence' concept stock list by Tonghuashun, citing its strategic cooperation framework agreement with iFLYTEK to jointly develop 'AI + Ophthalmology'.爱尔眼科被同花顺新增“人工智能”概念，因其与科大讯飞签订战略合作框架协议，共同打造“AI+眼科”。
2025-02-11Aier Eye Hospital disclosed that its proprietary ophthalmic vertical large model AierGPT covers tasks in optometry, refractive surgery, cataract, and fundus, providing training, guidance, auxiliary diagnosis, and science education.爱尔眼科披露其自主研发的眼科垂直大模型AierGPT涵盖视光、屈光、白内障和眼底等多个任务，提供培训、导诊、辅诊和科普服务。
2025-02-13Aier Eye Hospital stated its digital human 'Eyecho' integrates proprietary large model AierGPT and is developed in-house and in cooperation with the Institute of Computing Technology of the Chinese Academy of Sciences.爱尔眼科表示其数字人‘爱科(Eyecho)’搭载了自主研发的大模型AierGPT，以自主研发及与中国科学院计算技术研究所的深度合作为主。
2025-02-28Aier Eye Hospital's digital human 'Eyecho' completed multiple technical upgrades and officially integrated the DeepSeek R1 reasoning model, improving concurrent processing speed for clinical scenarios.爱尔眼科数字人‘爱科(Eyecho)’完成多项技术升级，正式接入DeepSeek R1推理模型，提升了并发处理速度，用于临床服务场景。
2025-03-04Aier Eye Hospital's digital human 'Eyecho' completed technical upgrades and officially connected to the DeepSeek R1 reasoning model, improving concurrent processing speed and enabling intelligent services across pre-, during-, and post-hospital clinical scenarios.爱尔眼科数字人“爱科（Eyecho）”完成技术升级，正式接入DeepSeek R1推理模型，优化并发处理速度，并应用于院前、院中、院后各临床服务场景。
2025-04-24Aier Eye Hospital launched an ophthalmic vertical large model and advanced digital strategy with 'AI + Ophthalmology' as the focus.爱尔眼科推出眼科垂直大模型，以“AI+眼科”为着力点推进数字战略。
2025-04-28Aier Eye Hospital deepened cooperation with iFlytek (科大讯飞) and the Chinese Academy of Sciences (中科院) to jointly build 'Aier AI Eye Hospital', advancing AI applications in ophthalmic services.爱尔眼科深化与科大讯飞及中科院的合作，携手打造“爱尔AI眼科医院”，推进AI在眼科服务中的应用。
2025-06-06Aier Eye Hospital Group independently developed digital human 'Aike (Eyecho)' and donated an 'Eye Health Digital Human Service Station' to Nanjing Chaotiangong Ethnic Primary School, integrating AI and ophthalmology for youth myopia prevention.爱尔眼科医院集团自主研发的数字人“爱科(Eyecho)”亮相，并向南京朝天宫民族小学捐赠“眼健康数字人服务站”，将人工智能技术与青少年眼健康管理深度融合。
2025-06-29Aier Eye Hospital Group signed an AI strategic cooperation agreement with Huawei Cloud at the opening ceremony of Shenzhen Binhai Aier Eye Hospital, focusing on AI-assisted diagnosis, smart health management, and hospital digitalization.爱尔眼科医院集团与华为云计算技术有限公司在深圳滨海爱尔眼科医院开诊仪式上签署AI战略合作协议，合作涵盖AI辅助诊断、智能健康管理及医院数字化升级。
2025-08-04AierGPT and Aier Digital Human, co-developed with the Chinese Academy of Sciences Institute of Computing Technology, won the Best Demo Award at ICCSE 2025 / ICAA 2025.爱尔眼科与中国科学院计算技术研究所共同研发的“AierGPT及爱尔数字人”在ICCSE 2025 / ICAA 2025上荣获最佳演示奖。
2025-09-06At the 'Ophthalmic Artificial Intelligence Symposium' held during the 29th Chinese Medical Association Ophthalmology Academic Conference (CCOS 2025), Aier Eye Hospital released the 'Aier Eye Hospital AI Strategy White Paper'.在中华医学会第二十九次眼科学术大会（CCOS 2025）期间的“眼科人工智能专题会”上，爱尔眼科发布了《爱尔眼科AI战略白皮书》。
2025-09-08Aier Eye Hospital detailed its AI strategy: built a 'five-in-one' AI smart hospital system covering the full cycle of 'prevention-healthcare-diagnosis-treatment-rehabilitation'; its 'Medical Cloud' platform accesses large models like DeepSeek for rapid report interpretation and assisted diagnosis; independently developed the 'ADP3.0 Intelligent Medical AI Platform' with multimodal large model management capabilities.爱尔眼科详细阐述AI战略：构建覆盖“预防-保健-诊断-治疗-康复”全周期的“五位一体”AI智慧医院体系；“医疗云”平台接入DeepSeek等大模型实现报告快速解读与辅助诊断；自主研发“ADP3.0智能医疗AI平台”，内置多模态大模型管理能力。
2025-11-21Aier Eye Hospital launched 'AierGPT', an ophthalmology-specific large model capable of automatic electronic medical record generation and outpatient record quality control. It also developed an AI fundus management system that identifies over 10 eye diseases, and an ocular surface AI mini-program for initial malignancy assessment of eyelid tumors via smartphone photos.爱尔眼科推出眼科垂类大模型“AierGPT”，实现电子病历自动生成和门诊病历质控；自主研发眼底AI管理系统可识别10余种眼病；眼表AI小程序支持手机拍照初判眼睑肿物良恶性。
2026-01-08Aier Eye Hospital's digital human 'Aike (Eyecho)' is in trial operation at some large hospitals, providing eye health education, hospital information consultation, and medication guidance, with plans for gradual rollout.爱尔数字人“爱科(Eyecho)”已在部分大医院试运行，提供眼健康科普、医院信息咨询、诊疗及用药注意事项等功能，并持续升级逐步推广。
2026-01-12Aier Eye Hospital confirmed it uses DeepSeek R1 and V3.2, and ChatGPT V5.1 and V5.2 for AI training, employing both RAG and fine-tuning methods.爱尔眼科确认使用DeepSeek R1和V3.2、ChatGPT V5.1和V5.2进行AI训练，采用RAG和微调训练方式。
2026-01-16Aier Eye Hospital led the 'Ophthalmic Ultrasound Intelligent Assisted Diagnosis System' project, which was selected for the 2025 National AI Medical Device Innovation Task 'Open Competition' list by MIIT and NMPA.由爱尔眼科牵头的“眼科超声智能辅助诊断系统”项目入选国家工信部、药监局2025年人工智能医疗器械创新任务“揭榜挂帅”入围名单。
2026-05-09Aier Eye Hospital's 'Fundus Screening AI Feature Dataset' was selected as one of the third batch of top ten typical cases for data intellectual property registration by the National Intellectual Property Administration.爱尔眼科“眼底筛查AI特征数据集”入选国家知识产权局数据知识产权登记第三批十大典型案例。
2026-06-05Aier Eye Hospital officially launched the 'AI Ophthalmology Management System', covering the full lifecycle of eye health, and is developing an 'AI Refractive Surgery Doctor' project covering 32 hospitals.爱尔眼科正式发布“AI眼科管理体系”，覆盖眼健康全生命周期，并正在研发覆盖32家医院的“AI屈光手术医生”项目。
Overseas expansion (Europe, UK, Southeast Asia, South America)海外扩张（欧洲、英国、东南亚、南美）
12 · 2024-06-05 → 2026-06-10
▾
Aier expanded globally through acquisitions in the UK (Optimax), Europe (Clinica Baviera), and South America (OPTY Group), and grew its Southeast Asian ISEC chain.爱尔通过收购英国Optimax、欧洲Clinica Baviera和南美OPTY集团实现全球扩张，并发展东南亚ISEC连锁。
2024-06-05Aier Eye Hospital's European subsidiary Clinica Baviera acquired 100% equity of UK-based Optimax Group (Eye Hospitals Group) for an undisclosed amount, entering the UK market.爱尔眼科欧洲子公司Clínica Baviera收购英国Optimax集团（Eye Hospitals Group）100%股权，进军英国市场。
2025-07-18Aier Eye Hospital disclosed that its acquired Spanish subsidiary Clínica Baviera S.A. achieved revenue of 260 million euros in 2024 with net profit CAGR over 20%; Singaporean subsidiary ISEC achieved revenue of 74 million Singapore dollars in 2024 with CAGR of about 20% since acquisition.爱尔眼科披露其收购的西班牙子公司Clínica Baviera S.A. 2024年收入2.6亿欧元，净利润年复合增速超20%；新加坡子公司ISEC 2024年收入0.74亿新元，自收购以来年复合增速约20%。
2026-01-12Aier Eye Hospital disclosed that its overseas revenue for 2022, 2023, 2024 was 1.935 billion, 2.312 billion, 2.625 billion yuan respectively, and H1 2025 overseas revenue was 1.517 billion yuan, accounting for about 13.19% of total revenue.爱尔眼科披露海外业务营收：2022年19.35亿元、2023年23.12亿元、2024年26.25亿元，2025上半年15.17亿元，占总营收约13.19%。
2026-03-12European Clínica Baviera delegation visited Aier Eye Hospital in Beijing for academic exchange and strategic signing, deepening China-Europe ophthalmic cooperation.欧洲巴伐利亚眼科集团代表团访问北京爱尔眼科医院，进行学术交流与战略签约，深化中欧眼科合作。
2026-03-18Aier Eye Hospital disclosed that overseas business revenue accounts for about 13%, and its European subsidiary acquired UK-based Optimax in mid-2024 to expand the global network.爱尔眼科披露海外业务收入占比约13%，2024年中期欧洲子公司收购英国Optimax，完善全球医疗网络。
2026-05-19Aier Eye Hospital Chairman Chen Bang stated at the general meeting that the company plans to seize overseas development opportunities and that H-share listing is a strategic step for globalization.爱尔眼科董事长陈邦在股东会上表示，公司将把握海外发展机会，H股上市是全球化战略的重要一步。
2026-05-27Aier Eye Hospital submitted an H-share listing application to the Hong Kong Stock Exchange, with Huatai International as the sole sponsor. As of end-2025, it operates 842 eye care institutions globally (663 domestic, 179 overseas).爱尔眼科向港交所提交H股上市申请，独家保荐人为华泰国际。截至2025年末，全球运营842家眼科医疗机构（境内663家，境外179家）。
2026-05-27Aier Eye Hospital's H-share prospectus disclosed a pending overseas acquisition意向, with only a non-legally binding memorandum of understanding signed as of the filing date.爱尔眼科H股招股书披露一项正在洽谈中的境外收购意向，截至公告日仅签署不具备法律约束力的谅解备忘录。
2026-06-09Aier Eye Hospital Group signed a cooperation agreement with South American healthcare investment institution Saúde Latam, formally completing the acquisition of OPTY Group, the largest chain of ophthalmic hospitals in South America.爱尔眼科医院集团与南美洲医疗投资机构Saúde Latam签署合作协议，正式完成对南美洲最大连锁眼科医院集团OPTY的收购。
2026-06-10Aier Eye Hospital announced that its wholly-owned subsidiary AIER Brazil will invest 530 million BRL (about 696 million yuan) to acquire a 60.57% stake in the target company, indirectly controlling Brazil's largest ophthalmology service group (OPTY Group).爱尔眼科公告，其全资子公司AIER Brazil拟投资5.30亿巴西雷亚尔（约6.96亿元人民币）收购目标公司60.57%股权，间接控制巴西最大眼科医疗服务集团（OPTY集团）。
2026-06-10Aier Eye Hospital disclosed in its investor relations record that as of end-2025, it operated 842 ophthalmic medical institutions globally, including 179 overseas, with overseas revenue accounting for about 14%.爱尔眼科在投资者关系记录中披露，截至2025年底全球运营842家眼科医疗机构，其中海外179家，海外业务收入占比约14%。
2026-06-10Aier Eye Hospital disclosed in its investor relations record that it is prudently evaluating emerging markets such as South America, which have large populations and strong ophthalmology demand.爱尔眼科在投资者关系记录中披露，正在审慎评估南美等新兴市场，这些区域人口基数大、眼科需求旺盛。
Minority investments & stakes少数股权投资与持股
2 · 2024-06-06 → 2025-12-14
▾
Equity investments in subsidiaries and portfolio companies, including IPO of invested firm.对子公司及投资组合公司的股权投资，包括被投企业IPO。
2024-06-06Aier Eye Hospital's subsidiary Chongqing Yanshiguang Eye Hospital completed a financing of 270 million yuan, with Aier Eye Hospital as the investor, post-investment valuation 325 million yuan.爱尔眼科子公司重庆眼视光眼科医院完成融资2.7亿元，爱尔眼科为投资方，投后估值3.25亿元。
2025-12-14Intalight Saiwei (Saiwei Technology), an ophthalmic intelligent diagnostic device firm backed by Aier's strategic investment in 2021, launched its IPO with Guotai Junan Hai Tong Securities as sponsor.爱尔眼科2021年战略投资的眼科智能诊疗设备企业赛炜科技（Intalight赛炜）启动IPO，辅导机构为国泰海通证券。
Fundraising project closures & capital management募投项目结项与资金管理
14 · 2024-06-09 → 2026-04-23
▾
Closure of fundraising projects, permanent supplementation of working capital, and use of idle funds for wealth management.募投项目结项、永久补充流动资金及使用闲置资金进行理财。
2024-06-09Aier Eye Hospital changed its registered capital from 9,328,411,413 yuan to 9,327,014,495 yuan, a reduction of approximately 1.4 million yuan.爱尔眼科注册资本由9,328,411,413元变更为9,327,014,495元，减少约140万元。
2024-07-19Aier Eye Hospital's board approved the conclusion of the 'Changsha Aier relocation and expansion project' (a 2021 private placement fundraising project) and the use of 10.0037 million yuan in surplus funds to permanently supplement working capital.爱尔眼科董事会审议通过“长沙爱尔迁址扩建项目”结项，将节余募集资金1000.37万元永久补充流动资金。
2024-08-29Aier Eye Hospital stated that capital expenditure for hospital acquisitions in 2025 is expected to be lower than in 2024, pending future announcements.爱尔眼科表示，2025年用于收购医院的资本支出预计低于2024年，具体情况以后续公告为准。
2024-09-20Aier Eye Hospital plans to use up to 500 million yuan of temporarily idle raised funds to purchase low-risk wealth management products.爱尔眼科拟使用不超过5亿元闲置募集资金购买低风险理财产品。
2024-11-05Aier Eye Hospital approved use of up to RMB 1 billion in idle自有资金 to purchase wealth management products; it subscribed RMB 100 million to 'CITIC Securities Wealth Private Investment Aier No.1 FOF' with a 4% performance benchmark.爱尔眼科同意使用不超过10亿元闲置自有资金购买理财产品；认购了‘中信证券财富私享投资爱尔1号FOF单一资产管理计划’1亿元，业绩比照基准4%。
2025-03-06Aier Eye Hospital's board approved the closure of two fundraising projects ('Hubei Aier New Project' and 'Anhui Aier New Project') and the permanent use of 105.8223 million yuan in surplus funds (including interest) to supplement working capital.爱尔眼科董事会批准“湖北爱尔新建项目”和“安徽爱尔新建项目”结项，将节余资金共计10,582.23万元（含利息）永久补充流动资金。
2025-07-16Aier Eye Hospital announced the 'Guizhou Aier New Project' (a fundraising project) is completed and will be closed, with remaining funds of 120 million yuan permanently added to working capital.爱尔眼科公告募投项目“贵州爱尔新建项目”已达到预定可使用状态并结项，节余资金1.2亿元永久补充流动资金。
2025-08-05Second extraordinary general meeting of 2025 approved the resolution to close certain fundraising projects and permanently supplement working capital with the surplus funds.2025年第二次临时股东大会审议通过部分募投项目结项并将节余募集资金永久补充流动资金的议案。
2025-08-08Used 150 million yuan of idle self-owned funds to purchase two medium-low risk wealth management products from Ningyin Wealth and CEB Wealth Management.使用1.5亿元闲置自有资金购买宁银理财和信银理财的两款中低风险理财产品。
2025-12-25Aier Eye Hospital used RMB 200 million of idle自有资金 (own funds) to subscribe to the Jiashi Bailing All-Weather Investment Advisory Portfolio, a low-to-medium risk product with a benchmark of PBOC 1-year deposit rate + 2%, starting December 24, 2025, redeemable anytime.爱尔眼科使用闲置自有资金2亿元认购嘉实百灵全天候投顾组合，中低风险，业绩比较基准为人民银行1年定期存款利率上浮2%，2025年12月24日起息，可随时赎回。
2026-01-28Aier Eye Hospital's Hong Kong subsidiary subscribed to Citibank dual-currency convertible deposit of EUR 2,736.70 million (approx. RMB 21.5 million) with a performance benchmark of 5.7%, from January 27 to April 28, 2026.爱尔眼科全资子公司爱尔眼科国际（香港）有限公司认购花旗银行双货币可转换存款2736.70万欧元（约2150万元人民币），业绩比较基准5.7%，期限2026年1月27日至4月28日。
2026-03-20Aier Eye Hospital's board approved the closure of the 'Shenyang Aier Eye Optometry Relocation and Expansion Project' and the use of 215.34 million yuan in surplus funds to permanently supplement working capital.爱尔眼科董事会批准“沈阳爱尔眼视光迁址扩建项目”结项，将节余资金2.1534亿元永久补充流动资金。
2026-03-20Aier Eye Hospital's board approved the use of up to 1.5 billion yuan of self-owned funds for cash management over a 12-month period.爱尔眼科董事会批准使用不超过15亿元自有资金进行现金管理，期限12个月。
2026-04-23Aier Eye Hospital's board approved a plan to apply for up to 6 billion yuan in comprehensive bank credit for 2026.爱尔眼科董事会批准2026年向银行申请不超过60亿元的综合授信额度。
New clinics, hospitals & facility expansion新诊所、医院及设施扩建
13 · 2024-07-10 → 2026-06-24
▾
Opening of new specialist clinics, hospital relocations, land acquisitions, and facility expansion projects.新专科门诊开设、医院迁址、土地购置及设施扩建项目。
2024-07-10Aier Eye Hospital (via Tianjin Liangjing Medical Management Co., Ltd.) successfully bid for a land parcel in Nankai District, Tianjin, to build Aier Eye Hospital Tianjin headquarters and Tianjin University Aier Eye Hospital.爱尔眼科（通过天津亮晶医疗管理有限公司）成功竞得天津市南开区一地块，将建设爱尔眼科天津总部与天津大学爱尔眼科医院。
2024-07-18Jinjiang Anhai Aier Eye Clinic signed a co-construction agreement with the CPC Dongli Community General Branch to establish an 'Eye Health Service Station' for community residents.晋江安海爱尔眼科门诊部与中共安海镇东鲤社区党总支部举行共建签约，设立“眼健康服务站”。
2025-03-05Qujing Aier Eye Hospital established an 'Intraocular Injection Base' to provide one-stop diagnosis and treatment for fundus diseases, addressing issues of difficult appointments, complex procedures, and long waits.曲靖爱尔眼科医院成立“眼内注药基地”，为眼底疾病患者提供一站式诊疗，解决预约难、流程繁、等待久等问题。
2025-03-24Aier Eye Hospital's subsidiary Tianjin Aier invested 130 million yuan in Tianjin Liangjing Medical Management Co., Ltd. to fund the relocation and expansion of Tianjin Aier, increasing its stake to 92.86%.爱尔眼科全资子公司天津爱尔向天津亮晶医疗管理有限公司增资1.3亿元，用于天津爱尔迁址扩建，持股比例升至92.86%。
2025-03-24Dali Aier Eye Hospital established an 'Intraocular Lens Myopia Surgery Clinic' specializing in ICL implantation, offering customized surgical plans within 3 hours and multi-disciplinary team consultations.大理爱尔眼科医院成立“眼内镜近视手术门诊”，专注ICL晶体植入术，提供3小时内定制手术方案及多学科团队会诊。
2025-05-12Dali Aier Eye Hospital (Yunnan) launched the first 'Allergic Eye Disease Specialist Clinic' in western Yunnan, introducing IgE testing for precise allergen detection.大理爱尔眼科医院成立滇西首个“过敏性眼病专科门诊”，引入IgE检测技术精准锁定眼部过敏原。
2025-05-13Wholly-owned subsidiary Shenzhen Binhai Aier Eye Hospital won the bid for 60% equity and specific claims of Shenzhen Guangshu Digital Technology Co., Ltd. (asset: Guangshu Kechuang Building) for 649.6 million yuan, to be used as long-term medical premises.全资子公司深圳滨海爱尔眼科医院以6.496亿元公开摘牌获得深圳广晟数码技术有限公司60%股权及特定债权，标的资产“广晟科创大厦”将作为长期医疗用房。
2025-09-04Aier Eye Hospital's controlled subsidiary Jiangmen Wuyi Aier New Hope Eye Hospital Co., Ltd. relocation and expansion project received environmental impact assessment approval in principle; total investment 20 million yuan.爱尔眼科控股子公司江门五邑爱尔新希望眼科医院有限公司迁扩建项目环评审批获原则同意，总投资额2000万元。
2025-11-25Aier Eye Hospital in Yuncheng, Shanxi, launched a presbyopia (老花眼) outpatient clinic integrating cataract, refractive surgery, and fundus departments, offering a one-stop diagnosis and treatment model for presbyopia, filling a gap in systematic presbyopia care in southern Shanxi.运城爱尔眼科医院开设老视门诊，整合白内障科、屈光手术科、眼底科等多学科资源，推出“一站式”老视诊疗模式，填补晋南地区老视系统化诊疗空白。
2026-03-11Aier Eye Hospital regained development rights for the Meixi Lake Phase II L06-D19-01/02 plot in Changsha, planning to build an eye health platform integrating medical services, R&D, and industrial incubation.爱尔眼科重新取得长沙梅溪湖二期L06-D19-01/02组团地块开发权，计划建设集医疗服务、科研创新、产业孵化于一体的眼健康平台。
2026-04-21Aier Eye Hospital launched 'Difficult Pediatric Eye Disease Specialist Clinic' and 'Difficult Strabismus and Amblyopia Specialist Clinic' in Guiyang, forming a 'one city, two hospitals' network.爱尔眼科在贵阳推出'疑难小儿眼病专家门诊'和'疑难斜弱视专家门诊'，形成'一城两院'格局。
2026-06-23Anhui Aier Eye Hospital partnered with Meimu Medical to launch customized artificial eye (ocular prosthesis) fitting services.安徽爱尔眼科医院与美目医疗合作，推出个性化义眼定制服务。
2026-06-24Jinan Aier Eye Hospital held a ceremony to establish a Traditional Chinese Medicine (TCM) Ophthalmology Clinic, officially launching integrated Chinese and Western medicine eye disease diagnosis and treatment services.济南爱尔眼科举行中医眼科门诊授牌仪式，正式开启中西医协同眼病诊疗服务。
Public welfare & community initiatives公益与社区活动
5 · 2024-08-14 → 2025-10-10
▾
Public welfare projects, eye care awareness days, community service stations, and volunteer service committees.公益项目、眼健康关爱日、社区服务站及志愿服务委员会。
2024-08-14Hubei Aier Eye Hospital established the first overseas returnees' association (Wuhan European and American Alumni Association) in a private enterprise in Wuhan.湖北爱尔眼科医院成立武汉欧美同学会（留学人员联谊会），为武汉首家成立归国留学人员联谊组织的民营企业。
2024-10-09Aier Eye Hospital held the 5th '1010 Dry Eye Care Day' science popularization event at Nanchang Aier Eye Hospital to raise public awareness of dry eye disease.爱尔眼科在南昌爱尔眼科医院举办第五届“1010干眼关爱日”科普宣传活动，提升公众对干眼症的认识。
2024-10-10Aier Eye Hospital released the 'Aier Children's Dry Eye Diagnosis and Treatment Guidance' and 'Multicenter Study on Normal Values of Children's Dry Eye' at the 5th '1010 Dry Eye Care Day' event, and announced the establishment of nearly 50 children's dry eye clinics nationwide.爱尔眼科在第五届“1010干眼关爱日”上发布《爱尔儿童干眼诊疗指导意见》与《儿童干眼正常值多中心研究》，并宣布已在全国成立近50家儿童干眼门诊。
2025-02-20China Association of Volunteers for the Disabled, China Blind Persons Association, and Hunan Aier Eye Charity Foundation jointly established the Special Committee for Blindness Prevention Volunteer Services; multiple Aier experts were appointed as specially invited experts.中国助残志愿者协会、中国盲人协会、湖南爱眼公益基金会共同发起成立防盲志愿服务联合专业委员会，多位爱尔眼科专家获聘为特聘专家。
2025-10-10Aier Eye Hospital Group held the 6th '1010 Dry Eye Care Day', jointly launching the 'Warm Veterans, Protect Vision' public welfare project with China Aging Development Foundation and Hunan Love Eye Public Welfare Foundation, releasing the 'Dry Eye Run Series Combined Treatment Plan' and 'Family Care Package', and launching the 'AI Dry Eye Doctor'.爱尔眼科医院集团举办第六届“1010干眼关爱日”，联合中国老龄事业发展基金会、湖南爱眼公益基金会发起“情暖老兵・守护光明”公益项目，发布“干眼‘润’系列联合治疗方案”及“家庭护理包”，上线“AI干眼医生”。
Defamation lawsuits & whistleblower disputes诽谤诉讼与举报人纠纷
5 · 2024-09-10 → 2025-04-03
▾
Aier won defamation lawsuits against online users and whistleblower Ai Fen, while also losing a related case.爱尔赢得针对网络用户和举报人艾芬的诽谤诉讼，同时也在一起相关案件中败诉。
2024-09-10Aier Eye Hospital was involved in a copyright ownership dispute as defendant; plaintiff Guangzhou Culture Co. withdrew the lawsuit.爱尔眼科作为被告的著作权权属纠纷案，原告广州文化公司撤回起诉。
2024-12-16Aier Eye Hospital won a first-instance defamation lawsuit against 10 Weibo users who posted malicious falsehoods; court ordered deletion, apology, and compensation.爱尔眼科起诉10名微博用户名誉权纠纷一审胜诉，法院判决删除内容、道歉并赔偿经济损失。
2024-12-22Lanzhou Intermediate People's Court rejected an appeal by a doctor (Ke) against Ai Fen in a criminal defamation case, upholding the lower court's dismissal.甘肃省兰州市中级人民法院驳回柯某某对艾芬诽罪刑事自诉的上诉，维持一审不予受理裁定。
2025-01-09The Taiyuan Intermediate People's Court of Shanxi Province issued a second-instance verdict in the defamation lawsuit filed by Taiyuan Aier Eye Hospital against Dr. Ai Fen, upholding the original judgment that Ai Fen must post an apology for 30 days and pay over 60,000 yuan in damages for spreading false claims about removing a patient's eyeball.山西省太原市中级人民法院对太原爱尔眼科医院诉艾芬名誉侵权案作出二审判决，驳回艾芬上诉，维持原判：艾芬需连续30天置顶道歉并赔偿经济损失6万余元。
2025-04-03Wuhan Jianghan District People's Court ruled in favor of Ai Fen in a defamation lawsuit against three Aier Eye Hospital executives (Duan, Liu, Liu), ordering them to delete content, apologize, and compensate. Aier responded that it would appeal, calling it employee personal behavior.武汉市江汉区人民法院对艾芬诉三名爱尔眼科高管（段某某、刘某某、刘某）名誉权纠纷案作出一审判决，判令删除内容、道歉并赔偿。爱尔回应称系员工个人行为，将上诉。
ICL surgery volume & STAAR partnershipICL手术量与STAAR合作
6 · 2024-09-12 → 2026-06-05
▾
Aier was awarded global No.1 in ICL surgery volume and established ICL training bases with STAAR Surgical.爱尔获全球ICL手术量第一认证，并与STAAR Surgical共建ICL培训基地。
2024-09-12STAAR Surgical awarded Aier Eye Hospital the 'ICL Surgery International Standardized Training Base' honor at ESCRS 2024; Aier also presented research on EVO ICL and AI.STAAR公司在ESCRS 2024上为爱尔眼科颁发“ICL手术国际规范化培训带教基地”荣誉；爱尔展示了EVO ICL与AI研究成果。
2024-12-07Guizhou Aier Eye Hospital launched an 'Intraocular Lens (ICL) Myopia Surgery Clinic' in partnership with STAAR Surgical, offering customized ICL procedures.贵州爱尔眼科医院与STAAR公司合作启动“眼内镜(ICL)近视手术门诊”，提供个性化ICL晶体植入术。
2025-05-24At the 5th EVO ICL International Forum in Shanghai, Aier was awarded 'Global Strategic Partner (2025)', 'Global No.1 in ICL Surgery Volume (2015-2024)', and 'Cumulative 550,000 ICL Surgeries'. Also launched the 'Shanghai Aier International Teleconsultation Center for Complex Eye Diseases'.在第五届EVO ICL眼内镜手术国际论坛上，爱尔眼科获授“全球战略合作伙伴（2025年）”“全球ICL手术量第一医疗机构（2015-2024）”及“累计ICL手术量突破55万例”牌匾，并揭牌“上海爱尔眼科疑难眼病国际远程会诊中心”。
2025-07-22Aier Eye Hospital announced its ICL (Implantable Collamer Lens) surgery volume exceeded 550,000 in 2025, and it has been ranked 'Global No.1 in ICL Surgery Volume (2015-2024)' for 10 consecutive years.爱尔眼科宣布2025年ICL手术量突破55万例，连续10年荣获“全球ICL手术量第一医疗机构（2015-2024）”称号。
2026-05-29Aier Eye Hospital Jiangsu region launched 'Presbyopia Correction MDT Outpatient' clinics in Nanjing, Wuxi, and Suzhou, and STAAR Surgical granted 'ICL V5 Clinical Application Center' designations to four hospitals in the region.爱尔眼科江苏省区在南京、无锡、苏州揭牌“老视矫正MDT门诊”，STAAR Surgical授予四家医院“ICL V5临床应用中心”。
2026-06-05Dali Aier Eye Hospital was awarded the 'EVO ICL (V5) Clinical Application Cooperation Center' and its director Hong Bo became the first certified EVO ICL (V5) expert in western Yunnan.大理爱尔眼科医院获评“EVO ICL（V5）临床应用合作中心”，院长洪波成为滇西首位EVO ICL（V5）认证专家。
Regulatory & compliance issues监管与合规问题
9 · 2024-11-19 → 2026-04-09
▾
Regulatory probes, consumer complaints, false advertising allegations, and related responses.监管调查、消费者投诉、虚假宣传指控及相关回应。
2024-11-19National Health Commission (NHC) found 4 Aier hospitals (Nanjing, Yangzhou, Bengbu, Xianning) suspected of issuing false diagnostic certificates after inspecting 93 Aier hospitals in Jiangsu, Anhui, Hubei provinces.国家卫健委在排查江苏、安徽、湖北三省93家爱尔眼科医院后，发现其中4家（南京、扬州、蚌埠、咸宁）涉嫌出具虚假诊断证明。
2024-11-20Aier Eye Hospital responded to the NHC probe, stating that the involved hospitals have been punished by local regulators, rectified, and responsible managers disciplined internally.爱尔眼科回应国家卫健委调查，称涉事医院已受到属地监管部门处罚并整改，集团已对相关负责人进行严肃处理。
2024-11-27Aier Eye Hospital's clinical application big data report on orthokeratology lenses was challenged; a whistleblower reported 37 Aier hospitals to local market regulators for allegedly exaggerating efficacy, with 10 cases filed.爱尔眼科发布的角膜塑形镜临床应用大数据报告遭质疑；举报人向37家地市级市场监管部门举报爱尔眼科夸大功效，其中10家立案。
2024-12-05Aier Eye Hospital was reported by a whistleblower for alleged false advertising by 37 hospitals; 10 local market regulators filed cases, 27 did not.爱尔眼科被举报37家医院涉嫌虚假广告宣传，10家市场监管部门立案，27家不立案。
2026-03-02Aier Eye Hospital added 3 consumer complaint records on the 12315 platform, involving false advertising and after-sales service issues; complaints were withdrawn.爱尔眼科新增3件消费者投诉公示，涉及虚假宣传和售后服务问题，投诉人撤回投诉。
2026-04-02Aier Eye Hospital received 2 new consumer complaints on the 12315 platform, one regarding after-sales service and one withdrawn.爱尔眼科在12315平台新增2件消费者投诉，一件涉及售后服务，一件已撤回。
2026-04-04Aier Eye Hospital Lanzhou received a new consumer complaint on the 12315 platform regarding after-sales service for glasses; a mediation agreement was reached.兰州爱尔眼科医院在12315平台新增一件关于眼镜售后服务的投诉，已达成调解协议。
2026-04-09Aier Eye Hospital's Hangzhou hospital president Pan was accused of sexual assault; suspended pending police investigation, police have filed an administrative case.杭州爱尔眼科医院院长潘某某被指控猥亵，已被停职调查，警方已行政立案。
2026-04-09Aier Eye Hospital Guiyang received a new consumer complaint on the 12315 platform regarding other issues; mediation was terminated.贵阳爱尔眼科医院在12315平台新增一件消费者投诉，调解终止。
Awards, certifications & accreditations奖项、认证与资质
10 · 2024-12-24 → 2026-05-15
▾
Receipt of hospital grade certifications, industry awards, and professional accreditations.获得医院等级认证、行业奖项及专业资质。
2024-12-24Aier Eye Hospital's 'Medical Ethics' series report was selected as a '2024 Enterprise Typical Communication Case' at the China Economic Media Conference.爱尔眼科“医德医风”系列报道入选2024中国经济传媒大会“2024年企业典型传播案例”。
2025-01-22Aier Eye Hospital received three authoritative certifications from Changsha Market Supervision Bureau: ISO9001 (Quality Management), ISO14001 (Environmental Management), and ISO45001 (Occupational Health and Safety Management).爱尔眼科获得长沙市市场监督管理局颁发的ISO9001质量管理体系、ISO14001环境管理体系和ISO45001职业健康安全管理体系三大权威认证。
2025-07-29Aier Eye Hospital chairman Chen Bang received the 'Outstanding Builder of Socialism with Chinese Characteristics' award at the 6th National Conference, a top honor for private entrepreneurs.爱尔眼科董事长陈邦在第六届全国非公有制经济人士优秀中国特色社会主义事业建设者表彰大会上获“优秀中国特色社会主义事业建设者”称号。
2025-09-04Aier Eye Hospital's three hospitals in Chengdu (Sichuan Eye Hospital, Chengdu Aier Eye Hospital, Chengdu East Aier Eye Hospital) all passed the acceptance of Chengdu Municipal Key Specialty, marking that the three hospitals have entered the ranks of municipal key specialties.爱尔眼科成都3家医院（四川眼科医院、成都爱尔眼科医院、成都东区爱尔眼科医院）均通过成都市医学重点专科验收，迈入“市重点”行列。
2025-11-28Aier Eye Hospital Chairman Chen Bang was elected Vice President of the China Glory Society (中国光彩事业促进会) at its 7th member congress.爱尔眼科董事长陈邦在中国光彩事业促进会第七次会员代表大会上当选副会长。
2025-12-30Loudi Aier Eye Hospital was officially certified as a Grade 2A (二级甲等) ophthalmic specialist hospital by the Loudi Municipal Health Commission.娄底爱尔眼科医院获娄底市卫生健康委员会正式确认为二级甲等眼科专科医院。
2026-04-02Aier Eye Hospital Chongqing General Hospital received the 'AMARIS PresbyMAX' certification from Gaoshi Medical for presbyopia correction surgery.爱尔眼科重庆总院获高视医疗授予'阿玛仕PresbyMAX迈可视老视矫正手术认证专家'称号。
2026-04-21Aier Eye Hospital Nanning received the German AMARIS brand certification for all-laser refractive surgery.南宁爱尔眼科医院获德国阿玛仕品牌授牌，认可其全激光近视手术技术。
2026-04-29Aier Eye Hospital Kunming was rated a 'Four-Star Dry Eye Treatment Center' at the 2026 China Dry Eye Rehabilitation Annual Conference.昆明爱尔眼科医院在2026中国干眼康复学术年会上获评'四星干眼诊疗中心'。
2026-05-15Aier Eye Hospital received the 'Drafting Unit of Medical Institution Optometry Diagnosis and Treatment Construction Standards' certificate from the China International Association for Promotion of Science and Technology Standardization Committee.爱尔眼科获中国国际科技促进会标准化工作委员会颁发“《医疗机构眼视光诊疗建设规范》起草单位”证书。
Social responsibility & charity programs社会责任与公益项目
3 · 2024-12-27 → 2025-11-29
▾
Aier released CSR reports, donated to disaster relief, and ran large-scale charity surgery programs for veterans and low-income groups.爱尔发布社会责任报告，向灾害救援捐款，并为老兵和低收入群体开展大规模公益手术项目。
2024-12-27Aier Eye Hospital reported 2023 charitable donations of 386 million yuan, approximately 1.5 million charity surgeries, and eye health screenings covering nearly 200 million person-times.爱尔眼科披露2023年度公益性捐赠达3.86亿元，累计实施公益救助约150万例，眼健康义诊和科普宣教覆盖近2亿人次。
2025-10-22Media report (NetEase Qingliu) alleged that Aier Eye Hospital Group's charitable funds flowed back to its own hospitals through the Hunan Love Eye Public Welfare Foundation, with over 55 million yuan paid to a charity foundation from 2021 to 2024, raising concerns about potential medical insurance fraud.网易清流工作室报道称，爱尔眼科医院集团通过湖南爱眼公益基金会，2021年至2024年向某慈善基金会支付超过5500万元，慈善资金疑似回流至自家医院，引发套取医保差价质疑。
2025-11-29Aier Eye Hospital, together with the Aier Eye Charity Foundation, donated HKD 5 million to support relief efforts for the fire disaster in Tai Po, Hong Kong.爱尔眼科联合爱眼公益基金会向香港大浦火灾受灾各方捐赠500万港币，支援紧急救援工作。
New drug & product introduction (Faricimab, Teprotumumab, Longjing IOL)新药与新产品引入（法瑞西单抗、替妥木单抗、龙晶PR）
11 · 2025-01-16 → 2026-05-25
▾
Aier introduced innovative drugs like Faricimab and Teprotumumab, and domestically produced Longjing PR IOLs.爱尔引入法瑞西单抗、替妥木单抗等创新药物，以及国产龙晶PR晶体。
2025-01-16Aier Eye Hospital used the innovative international ophthalmic drug Faricimab (Vabysmo) to treat wet age-related macular degeneration (nAMD), which entered the national medical insurance catalog, reducing patient injection frequency and costs.爱尔眼科使用国际眼科创新药物法瑞西单抗（Faricimab）治疗湿性年龄相关性黄斑变性（nAMD），该药已进入国家医保目录，减少患者注射次数和费用。
2025-04-02Fuzhou Aier Eye Hospital introduced Teprotumumab injection, becoming the first professional ophthalmic institution in Fujian Province to introduce China's first new drug for thyroid eye disease, marking the entry into precision targeted therapy.福州爱尔眼科医院引进替妥尤单抗注射液，成为福建省首家引入中国首款甲状腺眼病新药的专业眼科医疗机构，标志着进入精准靶向治疗时代。
2025-05-20The first domestically produced IGF-1R targeted drug for thyroid-associated ophthalmopathy (TAO), Tetuzumab (N01 injection), was clinically deployed in Aier Eye Hospitals across 16 cities, with a single-course cost only 1/15 of imported drugs.首款国产IGF-1R靶向药物替妥尤单抗（N01注射液）在全国16个城市的爱尔眼科医院投入临床应用，单疗程费用仅为进口药的1/15。
2025-06-10Fuzhou Aier Eye Hospital successfully performed the first batch of Longjing PR phakic intraocular lens implants, the first domestically developed aspheric IOL from Aibo Nuode, entering the 'Chinese smart manufacturing' era for refractive surgery.福州爱尔眼科医院成功实施全国首批龙晶®PR型有晶体眼人工晶状体植入术，这是爱博诺德公司研发的国内首款自主研发高次非球面有晶体眼人工晶状体，进入屈光手术“中国智造”时代。
2025-07-17Kunming Aier Eye Hospital introduced Tepezza (teprotumumab), a biologic targeted drug for thyroid eye disease, reducing the need for surgery and offering a more economical treatment option.昆明爱尔眼科医院引进替妥尤单抗（Tepezza），一种用于甲状腺眼病的生物靶向药物，可减少手术需求且治疗费用更经济。
2025-10-29Nanning Aier Eye Hospital received the 'Longjing PR 100 Cases Pioneer' certification and was designated as the first 'Longjing PR National Training Center' within the Aier Group, for implanting over 100 cases of Longjing PR aspheric phakic intraocular lenses (made by Aibo Medical).南宁爱尔眼科医院因龙晶PR非球面有晶体眼人工晶状体（爱博医疗生产）植入量突破100例，获“龙晶PR百例先锋”认证，并挂牌爱尔眼科集团首家“龙晶PR全国培训中心”。
2025-12-31Kunming Aier Eye Hospital became one of the first hospitals in Yunnan province to perform the latest-generation EVO+ ICL V5 intraocular lens implantation, previously only available at Hainan Boao Aier, expanding access to advanced myopia correction.昆明爱尔眼科医院成为云南省首批开展最新一代EVO+ ICL V5晶体植入术的医院，此前该技术仅在海南博鳌爱尔开展，扩大了先进近视矫正技术的可及性。
2026-01-07Aier Eye Hospital successfully performed the first batch of EVO+ ICL (V5) crystal implantation surgeries in Guangxi, Shanghai, Kunming, and Wuxi, marking the launch of a new-generation myopia correction technology with larger optical zone and improved night vision.爱尔眼科在广西、上海、昆明、无锡成功实施全国首批EVO+ ICL（V5）晶体植入手术，标志着新一代近视矫正技术（更大光学区、更优夜视力）正式落地。
2026-01-23Aier Eye Hospital stated that it has successively launched upgraded surgical techniques such as ICL V5, full femtosecond Pro, full femtosecond 4.0, and full light shaping in the past two years, reversing the average price decline trend.爱尔眼科表示近两年陆续推出ICL V5、全飞秒Pro、全飞秒4.0、全光塑等升级术式，成功扭转了均价下行趋势。
2026-01-28Loudi Aier Eye Hospital will launch an 'Intraocular Lens Myopia Surgery Clinic' on February 1, 2026, focusing on ICL crystal implantation with customized technology, expert, and service.娄底爱尔眼科医院将于2026年2月1日举行“眼内镜近视手术门诊”揭牌仪式，专为ICL晶体植入术适配人群打造特色诊疗平台。
2026-05-25Aier Eye Hospital established 33 thyroid eye disease (TED) specialist clinics across 22 cities nationwide, setting industry standards for specialist clinic construction.爱尔眼科在全国22座城市成立33家甲状腺眼病专病门诊，率先建立行业专病门诊建设标准。
Hong Kong IPO plan香港IPO计划
7 · 2025-05-20 → 2026-05-18
▾
Aier denied HK IPO plans in early 2025 but later confirmed preparations and filed for H-share listing in 2026.爱尔在2025年初否认港股IPO计划，但随后确认筹备并于2026年提交H股上市申请。
2025-05-20Chairman Chen Bang stated at the 2024 AGM that the company has no near-term plan for a Hong Kong IPO, citing strong fundraising ability, ample cash flow, and low bank loan rates.董事长陈邦在2024年度股东大会上表示，公司近期暂无港股上市计划，因筹资能力强、现金流充裕、银行贷款利息低。
2026-03-09Aier Eye Hospital is reportedly planning a Hong Kong IPO; the company responded that material information should be based on official announcements.据媒体报道，爱尔眼科正计划赴港上市；公司回应称以公告信息为准。
2026-03-17Confirmed by sources close to Aier Eye Hospital, the company has started preparations for a Hong Kong IPO.经接近爱尔眼科的知情人士确认，公司已着手准备赴港上市。
2026-04-16Aier Eye Hospital stated in an investor Q&A that its H-share listing on the Hong Kong Stock Exchange is subject to official announcements.爱尔眼科在投资者互动中表示，赴港交所上市以公告为准。
2026-04-23Aier Eye Hospital announced plans to issue H-shares and list on the main board of the Hong Kong Stock Exchange.爱尔眼科公告拟发行H股并在香港联交所主板上市。
2026-04-23Aier Eye Hospital's board approved the appointment of Zhongzhong Shenhu (Hong Kong) Fushun as the auditor for its H-share listing.爱尔眼科董事会批准聘请中审众环（香港）富信为H股上市的专项审计机构。
2026-05-18Aier Eye Hospital's 2025 annual general meeting approved 25 proposals, including the H-share listing plan on the Hong Kong Stock Exchange, with over 99.7% approval for H-share related proposals.爱尔眼科2025年年度股东会审议通过25项议案，包括H股上市计划，H股相关议案同意比例超99.7%。
Executive & governance changes高管与治理变更
7 · 2025-11-10 → 2026-05-11
▾
Board elections, senior management appointments, articles of association amendments, and internal system establishment.董事会选举、高管任命、公司章程修订及内部制度建立。
2025-11-10Aier Eye Hospital held the 44th meeting of the 6th Board of Directors, nominating Chen Bang, Li Li, and Wu Shijun as non-independent director candidates, and Gao Guolei, Liu Duan, and Tian Suhua as independent director candidates for the 7th Board of Directors.爱尔眼科召开第六届董事会第四十四次会议，提名陈邦、李力、吴士君为第七届董事会非独立董事候选人，高国垒、刘端、田素华为独立董事候选人。
2025-11-10Aier Eye Hospital announced amendments to its Articles of Association and registration of market entity changes.爱尔眼科公告修订公司章程并办理市场主体变更登记。
2025-11-10Aier Eye Hospital established internal systems including an external investment management system, a system to prevent capital occupation by controlling shareholders, an audit committee charter, and an external guarantee management system.爱尔眼科制定对外投资管理制度、防范控股股东资金占用制度、审计委员会工作细则、对外担保管理制度等内部制度。
2025-11-27Aier Eye Hospital appointed new senior management: Li Li as General Manager; Han Zhong, Wu Shijun, Liu Duoyuan, Tang Shibo, Yang Zhikuan, Wang Lihua, Feng Jun, Zhang Yan, and Zhang Yongmei as Deputy General Managers; Wu Shijun as Board Secretary; Mo Qiwen as CFO; Li Jinzhou and Li Mi as Securities Representatives.爱尔眼科聘任新高级管理人员：李力任总经理，韩忠、吴士君、刘多元、唐仕波、杨智宽、王丽华、冯珺、张艳、张咏梅任副总经理，吴士君任董事会秘书，莫绮雯任财务总监，李金洲、李密任证券事务代表。
2025-11-27Aier Eye Hospital elected Zhou Jianjun as employee representative director of the 7th Board of Directors at the 2025 first workers' congress.爱尔眼科2025年第一次职工代表大会选举周建军为第七届董事会职工代表董事。
2026-01-12Aier Eye Hospital completed the filing of its revised Articles of Association, which were approved by the board and shareholders in November 2025, covering governance, shareholder rights, board operations, and profit distribution.爱尔眼科完成修订后《公司章程》的备案手续，修订内容涉及公司治理、股东权利、董事会运作及利润分配等核心领域。
2026-05-11Aier Eye Hospital announced a change in sponsor representative for its 2021 private placement project, with Huatai United Securities appointing Xiao Jiasong to replace Ding Mingming.爱尔眼科公告，华泰联合证券委派肖家嵩接替丁明明担任2021年定增项目持续督导保荐代表人。
